<?xml version="1.0" encoding="UTF-8"?>
<!-- Generated on Tue, 14 Apr 2026 19:23:28 -0400 -->
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>    <title>Roth Capital Partners, LLC - News &amp; Media</title>
    <link>https://www.roth.com/news-media</link>
    <description>The latest news released by Roth Capital Partners, LLC</description>
    <language>en-us</language>
    <generator>Equisolve</generator>
    <image>
      <url>https://d1io3yog0oux5.cloudfront.net/_1fd0a83baed9da049e34b4602d4b4c3f/roth/logo.png</url>
      <title>Roth Capital Partners, LLC</title>
      <link>https://www.roth.com</link>
      <width>88</width>
      <height>31</height>
    </image>
    <item>
      <title>Roth Capital Partners acted as Sole Book-Running Manager for U.S. Energy Corp. (NASDAQ: USEG) in its recent $8.8 Million Follow-On Offering</title>
      <pubDate>Tue, 31 Mar 2026 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>OC Leader Board: Chasing America’s Field of Dreams</title>
      <pubDate>Mon, 30 Mar 2026 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Placement Agent Manager Battalion Oil Corporation (NYSE American: BATL) in its recent $15 Million Private Placement</title>
      <pubDate>Mon, 30 Mar 2026 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH to Host 38th Annual Conference March 22-24, 2026 in Dana Point, California</title>
      <pubDate>Mon, 16 Mar 2026 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth acted as Exclusive Financial Advisor to Standex International (NYSE:SXI) on its Divestiture of Federal Industries to AeriTek Global</title>
      <pubDate>Fri, 13 Mar 2026 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital acted as Exclusive Financial Advisor to Texas Mineral Resources Corp. (OTCQB:TMRC) on its agreed merger with USA Rare Earth, Inc. (Nasdaq:USAR)</title>
      <pubDate>Thu, 12 Mar 2026 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for AST SpaceMobile (ASTS) in its recent $1 Billion Convertible Senior Notes Offering</title>
      <pubDate>Tue, 10 Mar 2026 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for Select Water Solutions, Inc. (NYSE: WTTR) in its recent $201 Million Follow-On Offering</title>
      <pubDate>Fri, 27 Feb 2026 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Financial Advisor and Fairness Opinion Provider to Inspirato Incorporated</title>
      <pubDate>Fri, 20 Feb 2026 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for WhiteFiber, Inc. (Nasdaq: WYFI) in its recent $230 Million Convertible Senior Notes Offering</title>
      <pubDate>Fri, 20 Feb 2026 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH Expands Healthcare Platform with Strategic Additions Across Investment Banking, Institutional Sales, and Research</title>
      <pubDate>Thu, 12 Feb 2026 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Financial Advisor to Sonim Technologies (NASDAQ: SONM)</title>
      <pubDate>Wed, 11 Feb 2026 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Book-Running Manager for Colombier Acquisition Corp. (CLBR) in its recent $299 Million Initial Public Offering</title>
      <pubDate>Tue, 10 Feb 2026 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Byron Roth, Executive Chairman of Roth Capital Partners, to Receive Prestigious 2026 Horatio Alger Award</title>
      <pubDate>Tue, 27 Jan 2026 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for AST SpaceMobile, Inc. (NASDAQ: ASTS) in its $1.2 Billion Convertible Senior Notes Offering</title>
      <pubDate>Tue, 09 Dec 2025 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Book-Running Manager for Gloo Holdings, Inc. (GLOO) in its recent $78.3 Million IPO Offering</title>
      <pubDate>Tue, 02 Dec 2025 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Financial Advisor for PEDEVCO Corp. (NYSE American:PED) in its recent $181 Million Acquisition</title>
      <pubDate>Thu, 20 Nov 2025 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH to Host 14th Annual Technology Conference at the Hard Rock Hotel in New York City on November 19, 2025</title>
      <pubDate>Wed, 12 Nov 2025 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH and Sustain SoCal to Host 8th Annual Sustainability Private Capital Virtual Event on October 28-29, 2025</title>
      <pubDate>Fri, 24 Oct 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Lead Manager for WhiteFiber, Inc. (NASDAQ: WYFI) in its $183.3 Million IPO</title>
      <pubDate>Thu, 02 Oct 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York City</title>
      <pubDate>Wed, 01 Oct 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for TeraWulf Inc. (NASDAQ: WULF) in its $1.0 Billion Convertible Senior Notes Offering</title>
      <pubDate>Thu, 25 Sep 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH Further Expands its Equity Research Team with the Addition of Adam Walsh, MD and Nick Pope</title>
      <pubDate>Mon, 15 Sep 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH to Host 12th Annual Solar &amp; Storage Symposium at RE+ 2025 - Select Companies to Conduct Investor Meetings in Las Vegas, NV</title>
      <pubDate>Tue, 02 Sep 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for Intuitive Machines, Inc. (NASDAQ: LUNR) in its $345 Million Convertible Senior Notes Transaction</title>
      <pubDate>Wed, 20 Aug 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for Firefly Aerospace, Inc. (NASDAQ: FLY) in its recent $998.5 Million IPO</title>
      <pubDate>Thu, 14 Aug 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Joint Book-Running Manager for CapsoVision, Inc. (NASDAQ: CV) in its recent $28.2 Million IPO</title>
      <pubDate>Thu, 24 Jul 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Manager for Silver Pegasus Acquisition Corp. (NASDAQ: SPEG) in its recent $115 Million IPO</title>
      <pubDate>Tue, 22 Jul 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Joint Book-Running Manager for Redwire Corporation (NYSE: RDW) in its recent $260 Million Follow-On</title>
      <pubDate>Thu, 10 Jul 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for SiTime Corporation (NASDAQ: SITM) in its recent $402.5 Million Follow-On</title>
      <pubDate>Wed, 09 Jul 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Joint Book-Running Manager for Antalpha Platform Holding Company (NASDAQ: ANTA) in its $57 Million IPO</title>
      <pubDate>Tue, 08 Jul 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Lead Book-Running Manager for DoubleDown Interactive Co., Ltd. (NASDAQ: DDI) in its recent $42.5 Million Secondary Offering</title>
      <pubDate>Tue, 24 Jun 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Financial Advisor for Redwire Corporation (NYSE: RDW) in its Acquisition of Edge Autonomy Intermediate Holdings, LLC</title>
      <pubDate>Fri, 20 Jun 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH to Host 15th Annual London Conference on June 24-26, 2025</title>
      <pubDate>Mon, 16 Jun 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for Sable Offshore Corp. (NYSE: SOC) in its recent $295 Million Follow-On Offering</title>
      <pubDate>Tue, 03 Jun 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Announces the Addition of Kyle Bauser, Ph.D. to its Healthcare Research Team</title>
      <pubDate>Wed, 28 May 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Placement Agent for USA Rare Earth, Inc. (NASDAQ: USAR) in its $75 Million PIPE</title>
      <pubDate>Thu, 22 May 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Manager for OMS Energy Technologies, Inc. (NASDAQ: OMSE) in its recent $33 Million Initial Public Offering</title>
      <pubDate>Tue, 20 May 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Financial Advisor to Burger Construction on its Merger with HBC</title>
      <pubDate>Tue, 06 May 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Financial Advisor for AudioEye, Inc. (NASDAQ: AEYE) in Sourcing and Structuring its $20 Million Senior Secured Credit Facility</title>
      <pubDate>Thu, 24 Apr 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for AST SpaceMobile, Inc. (NASDAQ: ASTS) in its $460 Million Convertible Senior Notes Attach this to the transaction – AST SpaceMobile</title>
      <pubDate>Wed, 23 Apr 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Exclusive Financial Advisor for Asure Software, Inc. (NASDAQ: ASUR) in its $60 Million Credit Facility</title>
      <pubDate>Tue, 22 Apr 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Lead Manager for AudioEye, Inc. (NASDAQ: AEYE) in its $33 Million Follow-On</title>
      <pubDate>Thu, 17 Apr 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH Conference Celebrates 25 Years in Dana Point with Unforgettable Community Partnerships and Recognition</title>
      <pubDate>Thu, 17 Apr 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Joint Book-Running Manager for Gaia, Inc. (NASDAQ: GAIA) in its $8 Million Follow-On</title>
      <pubDate>Fri, 11 Apr 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for EZCORP, Inc. (Nasdaq:EZPW) in its $300 Million Senior Notes Offering</title>
      <pubDate>Thu, 10 Apr 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Alex and Shelby Nowak Strengthen ROTH’s Healthcare Investment Banking Division</title>
      <pubDate>Fri, 04 Apr 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Financial Advisor to A-Mark Precious Metals’ Special Committee (Nasdaq:AMRK) in its Acquisition of Spectrum Group International</title>
      <pubDate>Thu, 20 Mar 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>37th Annual ROTH Conference: Key Takeaways</title>
      <pubDate>Tue, 18 Mar 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH to Host 37th Annual Conference March 16-18 in Dana Point, California</title>
      <pubDate>Mon, 10 Mar 2025 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for Turning Point Brands, Inc. (NYSE: TPB) in its $300 Million Senior Secured Notes Offering</title>
      <pubDate>Wed, 05 Mar 2025 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Financial Advisor on Twin Hospitality Group’s (NASDAQ: TWNP) spin-off from FAT Brands (NASDAQ: FAT)</title>
      <pubDate>Tue, 25 Feb 2025 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Advises Ceragon Networks (NASDAQ:CRNT) on its Acquisition of End 2 End Technologies</title>
      <pubDate>Mon, 10 Feb 2025 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Announces the New Location of Our New York City Office</title>
      <pubDate>Tue, 04 Feb 2025 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Book-Running Manager for U.S. Energy Corp. (NASDAQ: USEG) in its recent $12 Million Follow-On Offering</title>
      <pubDate>Thu, 30 Jan 2025 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as M&amp;A advisor to Film Finances Inc. on its Section 363 sale to creditors</title>
      <pubDate>Wed, 29 Jan 2025 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Book-Running Manager for Lakeland Fire + Safety (Nasdaq:LAKE) in its $46 million Follow-On</title>
      <pubDate>Wed, 29 Jan 2025 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH Corporate Access Team  - Our 2024 Year In Review</title>
      <pubDate>Tue, 14 Jan 2025 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH Expands Sales and Trading Team with Five Strategic Hires</title>
      <pubDate>Fri, 10 Jan 2025 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH Deepens Commitment to the Technology Sector with Key Team Expansions in Banking and Research </title>
      <pubDate>Tue, 07 Jan 2025 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Placement Agent for PSQ Holdings, Inc. (NYSE: PSQH) in its $36.2 million Registered Direct</title>
      <pubDate>Mon, 06 Jan 2025 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for Solaris Energy Infrastructure, Inc. (NYSE: SEI) in its recent $181 Million Follow-On Offering</title>
      <pubDate>Fri, 27 Dec 2024 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Agent for D-Wave Quantum Inc. (NYSE: QBTS) in its Completed $175 Million ATM Program</title>
      <pubDate>Mon, 23 Dec 2024 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Joint Book-Running Manager for zSpace, Inc. (NASDAQ: ZSPC) in its $10.8 Million IPO</title>
      <pubDate>Mon, 16 Dec 2024 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Manager for Jackson Acquisition Company II (NYSE: JACS.U) in its $230 Million IPO</title>
      <pubDate>Fri, 13 Dec 2024 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for indie Semiconductor, Inc. (Nasdaq:INDI) in its $219 Million Convertible Senior Note Offering</title>
      <pubDate>Thu, 12 Dec 2024 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Book-Running Manager for Intuitive Machines, Inc. (Nasdaq:LUNR) in its $115 Million Follow-On</title>
      <pubDate>Wed, 11 Dec 2024 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Book-Running Manager for Synergy CHC Corp. (NASDAQ: SNYR) in its $10 Million IPO</title>
      <pubDate>Tue, 03 Dec 2024 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Exclusive Financial Advisor to Bidadoo, Inc. in its recent Strategic Growth Financing</title>
      <pubDate>Mon, 02 Dec 2024 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH and Sustain SoCal to Host 7th Annual Sustainability Private Capital Virtual Event on December 4-5, 2024</title>
      <pubDate>Tue, 26 Nov 2024 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for Kura Sushi USA, Inc. (Nasdaq: KRUS) in its $68 Million Follow-On</title>
      <pubDate>Tue, 19 Nov 2024 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH to Host 13th Annual Technology Conference at the Hard Rock Hotel in New York City</title>
      <pubDate>Tue, 12 Nov 2024 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH Welcomes New Co-Heads to Lead Innovations Banking Sector </title>
      <pubDate>Mon, 11 Nov 2024 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Lead Agent for Evolution Petroleum Corp. (NYSE American: EPM) in its $30 Million ATM Program</title>
      <pubDate>Thu, 31 Oct 2024 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Capital Markets Advisor to Rezolve AI Limited (Nasdaq: RZLV) on its Business Combination with Armada Acquisition Corp. I (Nasdaq: AACI)</title>
      <pubDate>Thu, 17 Oct 2024 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH to Host 3rd Annual Healthcare Opportunities Conference on October 9 in New York City</title>
      <pubDate>Wed, 02 Oct 2024 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for Viper Energy, Inc. (NYSE: VNOM) in its recent $488 Million Follow-on Offering</title>
      <pubDate>Tue, 17 Sep 2024 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH to Host 11th Annual Solar &amp; Storage Symposium at RE+ 2024 - Select Companies to Conduct Investor Meetings in Anaheim, CA</title>
      <pubDate>Wed, 04 Sep 2024 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Joint Lead Book-Running Manager for CPI Card Group Inc. (NASDAQ: PMTS) in its recent Senior Secured Notes offering</title>
      <pubDate>Mon, 26 Aug 2024 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Joint-Lead Manager for Core Scientific, Inc. (NASDAQ: CORZ) in its $460 Million Convertible Senior Notes</title>
      <pubDate>Wed, 21 Aug 2024 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Book-Running Manager and Sole Placement Agent for MultiSensor AI Holdings, Inc. (Nasdaq: MSAI) in its $11.5 Million Follow-On Offering and $15 Million Private Placement, for a total of $26.5 Million</title>
      <pubDate>Fri, 12 Jul 2024 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Announces the Addition of Benjamin E. Paluch, Ph.D. and Boobalan Pachaiyappan, Ph.D. to its Healthcare Research Team</title>
      <pubDate>Mon, 08 Jul 2024 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH to Host 10th Annual London Conference on June 25-27, 2024</title>
      <pubDate>Mon, 17 Jun 2024 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for Alarm.com Holdings, Inc. (Nasdaq: ALRM) in its $500 Million Convertible Senior Notes</title>
      <pubDate>Thu, 06 Jun 2024 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Co-Manager for AZZ Inc. (NYSE: AZZ) in its $322 Million Follow-On</title>
      <pubDate>Thu, 30 May 2024 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Placement Agent for Genasys Inc.(Nasdaq: GNSS) in its $15 Million Senior Term Loan</title>
      <pubDate>Thu, 23 May 2024 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Sole Book-Running Manager for Sow Good Inc. (Nasdaq: SOWG) in its $13.8 Million Follow-On and Nasdaq Uplisting</title>
      <pubDate>Thu, 16 May 2024 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Join ROTH at Octane&apos;s Tech Innovation Forum on May 1 - 2 in Irvine, CA</title>
      <pubDate>Tue, 23 Apr 2024 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM acted as Active Joint Book-Running Manager to Riley Exploration Permian, Inc. (NYSE American: REPX) in its $65 Million Follow-On</title>
      <pubDate>Thu, 11 Apr 2024 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM acted as Co-Manager for Astera Labs, Inc. (Nasdaq: ALAB) in its $819 Million IPO</title>
      <pubDate>Tue, 02 Apr 2024 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM acted as Sole Placement Agent Manager for Danimer Scientific, Inc. (NYSE: DNMR) in its recent Registered Direct Offerings</title>
      <pubDate>Mon, 01 Apr 2024 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM Acted as Placement Agent Beyond Air, Inc. (NASDAQ: XAIR) in its $16 Million Registered Direct</title>
      <pubDate>Wed, 27 Mar 2024 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH to Host 36th Annual Conference March 17-19 in Dana Point, California</title>
      <pubDate>Mon, 11 Mar 2024 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM Acted as Sole Placement Agent for Biofrontera Inc. (NASDAQ:BFRI) in its $16.0 Million PIPE</title>
      <pubDate>Wed, 28 Feb 2024 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH MKM acted as Sole Placement Agent Manager for Phunware, Inc. (Nasdaq: PHUN) in its recent Follow-On Offerings</title>
      <pubDate>Thu, 22 Feb 2024 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH MKM acted as Co-Manager for Rocket Lab USA, Inc. (Nasdaq: RKLB) in its $355 Million Convertible Senior Notes Offering</title>
      <pubDate>Wed, 14 Feb 2024 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH MKM Acted as Sole Placement Agent for Tenax Therapeutics, Inc. (Nasdaq: TENX) in its $9 Million Follow-On</title>
      <pubDate>Tue, 13 Feb 2024 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH MKM Acted as Financial Advisor for BioRestorative Therapies, Inc. (NASDAQ: BRTX) in its $8.1 Million Warrant Exchange Offering</title>
      <pubDate>Mon, 12 Feb 2024 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH MKM Acted as Sole Placement Agent for Revelation Biosciences Inc. (NASDAQ: REVB) in its $6.2 Million Follow-On</title>
      <pubDate>Thu, 08 Feb 2024 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH MKM Acted as Co-Manager for Mama’s Creations, Inc. (Nasdaq: MAMA) in its $19.7 Million Follow-On</title>
      <pubDate>Wed, 07 Feb 2024 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH MKM Acted as Sole Placement Agent for Panbela Therapeutics, Inc. (Nasdaq: PBLA) in its $9 Million Follow-On</title>
      <pubDate>Thu, 01 Feb 2024 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH MKM acted as Co-Manager to Talos Energy, Inc. (NASDAQ: TALO) in its $403 Million Follow-On</title>
      <pubDate>Thu, 25 Jan 2024 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH MKM Acted as Sole Placement Agent for The Beachbody Company, Inc. (NYSE: BODY) in its $5.3 Million Registered Direct</title>
      <pubDate>Wed, 20 Dec 2023 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH MKM and Sustain SoCal to Host 6th Annual Sustainability Private Capital Virtual Event on December 6-7, 2023</title>
      <pubDate>Mon, 04 Dec 2023 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH MKM Acted as Sole Book-Running Manager for Shimmick Corporation (Nasdaq: SHIM) in its $25 Million Initial Public Offering</title>
      <pubDate>Thu, 30 Nov 2023 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH MKM Acted as Sole Placement Agent for Biofrontera Inc. (Nasdaq: BFRI) in its $4.5 Million Registered Direct Offering</title>
      <pubDate>Mon, 20 Nov 2023 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH MKM to Host the 12th Annual New York Technology Conference at the Yale Club in New York City</title>
      <pubDate>Mon, 13 Nov 2023 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH MKM to Host 3rd Annual AgTech Answers Event on November 14th in New York City</title>
      <pubDate>Thu, 09 Nov 2023 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH MKM Announces the Addition of Jason Wittes to its Healthcare Research Team</title>
      <pubDate>Thu, 12 Oct 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM acted as Sole Book-Running Manager for Genasys Inc. (NASDAQ: GNSS) in its $11.5 Million Follow-On</title>
      <pubDate>Mon, 09 Oct 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM to Host Healthcare Opportunities Conference on October 12th at the Yale Club in New York City</title>
      <pubDate>Mon, 09 Oct 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM to Host Healthcare Opportunities Conference on October 12th at the Yale Club in New York City</title>
      <pubDate>Mon, 09 Oct 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM Invites You to the PV CellTech USA Conference, October 3-4, San Francisco CA</title>
      <pubDate>Wed, 27 Sep 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM acted as Financial Advisor to SafePointe on it&apos;s Acquisition by SoundThinking (NASDAQ: SSTI)</title>
      <pubDate>Fri, 15 Sep 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM Announces the Addition of Sustainability Analyst Chip Moore, CFA - Managing Director and Senior Research Analyst</title>
      <pubDate>Mon, 11 Sep 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM acted as Lead Agent for Riley Exploration Permian, Inc. (NASDAQ:REPX) in its $50 Million ATM Program</title>
      <pubDate>Thu, 07 Sep 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM to Host 10th Annual Solar &amp; Storage Symposium at Solar Power International &amp; RE+ 2023</title>
      <pubDate>Wed, 06 Sep 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM Acted as Sole Placement Agent for Netlist, Inc. (OTCQB:NLST) in its $30 Million Registered Direct Offering</title>
      <pubDate>Wed, 30 Aug 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM Acted as Joint Placement Agent for Global Crossing Airlines Group, Inc. (NEO:JET) in its $35 Million Senior Secured Notes Placement</title>
      <pubDate>Thu, 10 Aug 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM Announces Additions to its SPAC Capital Markets Group</title>
      <pubDate>Thu, 03 Aug 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM Announces the Addition of Doug Gonsalves as Head of Technology Investment Banking</title>
      <pubDate>Wed, 02 Aug 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM acted as Sole Manager for HighPeak Energy (NASDAQ:HPK) in its $156 Million Follow-On</title>
      <pubDate>Wed, 26 Jul 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM Acted as Sole Book-Running Manager for GEN Restaurant Group, Inc. (Nasdaq: GENK) in its Upsized $49.7 Million Initial Public Offering</title>
      <pubDate>Tue, 11 Jul 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM Acted as Sole Placement Agent for Nautilus, Inc. (NYSE:NLS) in its $5 Million Registered Direct</title>
      <pubDate>Mon, 26 Jun 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM Acted as Sole Placement Agent Panbela Therapeutics, Inc. (Nasdaq: PBLA) in its $8.5 Million Follow-On</title>
      <pubDate>Mon, 26 Jun 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM to Host 9th Annual London Conference on June 20-22, 2023</title>
      <pubDate>Tue, 13 Jun 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM Acted as Sole Manager for Biote Corp. (Nasdaq: BTMD) in its $31 Million Follow-On</title>
      <pubDate>Mon, 12 Jun 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM Congratulates RX3 on Raising $150M Fund</title>
      <pubDate>Thu, 11 May 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Aaron Rodgers’ Fund Backed by Josh Allen, Christina Aguilera</title>
      <pubDate>Tue, 09 May 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Aaron Rodgers-Founded Firm Raises $150 Million Fund</title>
      <pubDate>Tue, 09 May 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM Acted as Co-Manager for Kura Sushi USA, Inc. (Nasdaq: KRUS) in its $68 Million Follow-On</title>
      <pubDate>Mon, 17 Apr 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM&apos;s Agribusiness Investment Banking Group Sees Success with the Closing of Three M&amp;A Sellside Transactions</title>
      <pubDate>Tue, 11 Apr 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM Acted as Sole Placement Agent for RenovoRx, Inc. (Nasdaq: RNXT) in its $5 Million Registered Direct</title>
      <pubDate>Mon, 10 Apr 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM Announces the Addition of Dylan Dupuis, Ph.D. to its Healthcare Research Team</title>
      <pubDate>Mon, 13 Mar 2023 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH MKM Releases its 2023 Millennial Survey</title>
      <pubDate>Tue, 07 Mar 2023 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH MKM to Host 35th Annual Roth Conference from March 12-14 in Dana Point, California</title>
      <pubDate>Mon, 06 Mar 2023 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH MKM Acted as Co-Manager for Purple Innovation, Inc. (Nasdaq: PRPL) in its $60 Million Follow-On</title>
      <pubDate>Fri, 24 Feb 2023 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH MKM Acted as Co-Manager for Xponential Fitness, Inc. (NYSE: XPOF) in its $141 Million Follow-On</title>
      <pubDate>Wed, 22 Feb 2023 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH MKM Acted as Sole Placement Agent for Revelation Biosciences, Inc. (Nasdaq: REVB) in its $15.6 Million Follow-On</title>
      <pubDate>Thu, 16 Feb 2023 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH MKM Acted as Sole Placement Agent for Tenax Therapeutics, Inc. (Nasdaq: TENX) in its $15.6 Million Follow-On</title>
      <pubDate>Thu, 09 Feb 2023 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Lead Placement Agent for Panbela Therapeutics, Inc. (Nasdaq: PBLA) in its $15 Million Follow-On</title>
      <pubDate>Mon, 06 Feb 2023 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Completes Acquisition of MKM Partners</title>
      <pubDate>Wed, 01 Feb 2023 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Joint Book-Running Manager for Biote Corp. (Nasdaq: BTMD) in its $26 Million Follow-On </title>
      <pubDate>Wed, 11 Jan 2023 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Financial Advisor to Greeley and Hansen on its Acquisition by TYLin</title>
      <pubDate>Mon, 09 Jan 2023 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners and Sustain SoCal to Host 5th Annual Sustainability Private Capital Virtual Event on December 7-8, 2022</title>
      <pubDate>Thu, 01 Dec 2022 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH Capital Partners, NGO Sustainability and the Permanent Mission of the Republic of Moldova to the UN to Host Side Event</title>
      <pubDate>Tue, 29 Nov 2022 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host 11th Annual Roth Technology Event</title>
      <pubDate>Fri, 11 Nov 2022 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH Capital Partners to Host 2nd Annual AgTech Answers Event on November 15th in New York City</title>
      <pubDate>Thu, 10 Nov 2022 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH Capital Partners Acted as Lead Placement Agent for Panbela Therapeutics, Inc. (Nasdaq:PBLA) in its $6 Million Follow-On</title>
      <pubDate>Wed, 12 Oct 2022 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH Capital Partners Announces the Addition of Kumaraguru Raja, Ph.D. to its Healthcare Research Team</title>
      <pubDate>Tue, 11 Oct 2022 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH Capital Partners to Host Inaugural Healthcare Opportunities Conference on October 6th at the Yale Club in New York City</title>
      <pubDate>Tue, 04 Oct 2022 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Capital Markets Advisor to Wag Labs, Inc. (Nasdaq:PET) on it&apos;s Business Combination with CHW Acquisition Corp. (Nasdaq:CHWA)</title>
      <pubDate>Tue, 20 Sep 2022 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH Capital Partners to Host 9th Annual Solar &amp; Storage Symposium at Solar Power International &amp; RE+ 2022</title>
      <pubDate>Thu, 15 Sep 2022 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>UC San Diego Moores Cancer Center 18th Industry/Academia Next-Generation Precision Oncology Symposium to be held on September 15</title>
      <pubDate>Thu, 01 Sep 2022 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Sole Manager for Global Water Resources, Inc. (Nasdaq:GWRS) in its $15.5 Million Follow-On</title>
      <pubDate>Wed, 17 Aug 2022 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Expands Its Institutional Brokerage Capabilities With Acquisition of MKM Partners, LLC</title>
      <pubDate>Wed, 17 Aug 2022 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Lead Placement Agent for Helius Medical Technologies, Inc. (Nasdaq:HSDT) in its $18 Million Follow-On</title>
      <pubDate>Wed, 10 Aug 2022 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Sole Placement Agent for Ontrak Inc. (Nasdaq:OTRK) in its $4 Million Registered Direct</title>
      <pubDate>Tue, 09 Aug 2022 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Sole Placement Agent for Revelation Biosciences Inc. (Nasdaq:REVB) in its $5 Million Follow-On</title>
      <pubDate>Thu, 04 Aug 2022 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Co-Manager for Cadre Holdings, Inc. (NYSE:CDRE) in its $94 Million Follow-On</title>
      <pubDate>Thu, 30 Jun 2022 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth to Host 8th Annual London Conference on June 21-23, 2022</title>
      <pubDate>Tue, 14 Jun 2022 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Lead Placement Agent for Tellurian Inc. (NYSE:TELL) in its $500 Million Senior Secured Convertible Notes</title>
      <pubDate>Thu, 09 Jun 2022 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Sole Agent for Creative Medical Technology (Nasdaq:CELZ) in its $17 Million PIPE</title>
      <pubDate>Wed, 18 May 2022 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth to Host Canada Showcase Day on May 17 in New York City</title>
      <pubDate>Mon, 09 May 2022 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Co-Manager for Xponential Fitness, Inc. (NYSE:XPOF) in its $104 Million Follow-On</title>
      <pubDate>Tue, 19 Apr 2022 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Sole Placement Agent for Applied DNA Sciences (NASDAQ:APDN) in its $4.2 Million Registered Direct Offering</title>
      <pubDate>Thu, 10 Mar 2022 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Financial Advisor to JustCBD on its Sale to Flora Growth Corp. (Nasdaq:FLGC)</title>
      <pubDate>Wed, 09 Mar 2022 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host 34th Annual Conference as In-Person Event March 13-15, 2022</title>
      <pubDate>Mon, 07 Mar 2022 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Sole Placement Agent for Revelation Biosciences Inc. (NASDAQ:REVB) in its $7.8 Million PIPE Offering</title>
      <pubDate>Tue, 08 Feb 2022 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Financial Advisor to Pedego on its Investment from Verlinvest</title>
      <pubDate>Thu, 06 Jan 2022 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Joint Book-Running Manager for Revelstone Capital Acquisition Corp. (Nasdaq:RCACU) in its $150 Million IPO</title>
      <pubDate>Wed, 05 Jan 2022 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Announces the Addition of Mike Niehuser, Managing Director and Senior Research Analyst - Covering Metals &amp; Mining Stocks</title>
      <pubDate>Tue, 21 Dec 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Sole Book-Running Manager for Genenta Science S.p.A. (NASDAQ:GNTA) in its approximately $36 Million IPO</title>
      <pubDate>Mon, 20 Dec 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for Northern Oil &amp; Gas, Inc. (NYSE:NOG) in its $230 Million Follow-On</title>
      <pubDate>Wed, 08 Dec 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Sole Manager for BioRestorative Therapies, Inc. (NASDAQ:BRTX) in its $23 Million Follow-On</title>
      <pubDate>Tue, 07 Dec 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Joint Book-Running Manager for Fathom Holdings, Inc. (Nasdaq:FTHM) in its $43.7 Million Follow-On</title>
      <pubDate>Fri, 03 Dec 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners and Sustain SoCal to Host Sustainability Private Capital Virtual Event on December 2-3, 2021</title>
      <pubDate>Mon, 29 Nov 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Joint Book-Running Manager for Biofrontera, Inc. (NASDAQ:BFRI) in its $18 Million IPO</title>
      <pubDate>Mon, 29 Nov 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Co-Manager for Cadre Holdings, Inc. (NYSE:CDRE) in it&apos;s $90 Million IPO</title>
      <pubDate>Mon, 22 Nov 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Joint Book-Running Manager for Clarus Corporation (Nasdaq:CLAR) in its $85 Million Follow-On</title>
      <pubDate>Mon, 15 Nov 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Virtually Host 10th Annual Roth Technology Event</title>
      <pubDate>Mon, 15 Nov 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Provides Agenda Details of Inaugural AgTech Answers Event</title>
      <pubDate>Thu, 11 Nov 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Book-Running Manager for HighPeak Energy (NASDAQ:HPK) in its $25.3 Million Follow On Offering</title>
      <pubDate>Mon, 08 Nov 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Financial Advisor for Myomo, Inc. (NYSE:MYO) in its $5 Million Warrant Exchange</title>
      <pubDate>Fri, 05 Nov 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Joint Book-Running Manager for SportsMap Tech Acquisition Corp. (SMAPU) in its $115 Million IPO</title>
      <pubDate>Thu, 04 Nov 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Announces the Addition of Sean McGowan, Managing Director and Senior Research Analyst, Covering Beverage, Wellness and Leisure Stocks</title>
      <pubDate>Mon, 01 Nov 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Co-Manager for Rezolute (NASDAQ:RZLT) in its $55 Million Follow-On</title>
      <pubDate>Fri, 29 Oct 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Joint-Placement Agent for PEDEVCO Corp. (NYSE:PED) in its $7 Million Registered Direct Offering</title>
      <pubDate>Wed, 27 Oct 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Announces the Addition of Edward Engel, CFA, Senior Research Analyst, Covering Gaming and Leisure Stocks</title>
      <pubDate>Wed, 20 Oct 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Announces the Addition of Edward Engel, CFA, Senior Research Analyst, Covering the Gaming &amp; Leisure Stocks</title>
      <pubDate>Tue, 19 Oct 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Financial Advisor to GP Strategies (NYSE:GPX) on its Sale of EtaPRO to Toshiba</title>
      <pubDate>Mon, 11 Oct 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Sole Book-Running Manager for RenovoRx, Inc. (RNXT) in its $16.7 Million IPO</title>
      <pubDate>Wed, 22 Sep 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Provides Agenda Details of the Investing in Women Cannabis Pioneers Investor Conference</title>
      <pubDate>Tue, 21 Sep 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Investing In Women Cannabis Pioneers: 25 Leaders, One Event And All You Need To Know</title>
      <pubDate>Thu, 16 Sep 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>IBN (InvestorBrandNetwork) to Serve as Media Sponsor for Roth’s Upcoming Event: Investing in Women Cannabis Pioneers Investor Conference</title>
      <pubDate>Tue, 14 Sep 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Co-Manager for F45 Training Holdings Inc. (NYSE:FXLV) in its $350 Million IPO</title>
      <pubDate>Wed, 08 Sep 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Virtually Host the Inaugural Investing in Women Cannabis Pioneers Investor Conference on September 28, 2021</title>
      <pubDate>Wed, 08 Sep 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Sole Placement Agent for Creative Medical Technology Holdings, Inc. (CELZ) in its $3.8 Million Private Placement</title>
      <pubDate>Fri, 03 Sep 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Sole Book-Running Manager for TransAct Technologies, Inc. (Nasdaq:TACT) in its $12.2 Million Follow-On</title>
      <pubDate>Tue, 31 Aug 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Beyond competition: How women in the industry are lifting each other up</title>
      <pubDate>Thu, 26 Aug 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Announces the Addition of Brian Wright, Senior Research Analyst, Covering the AgTech Sector</title>
      <pubDate>Thu, 26 Aug 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acted as Co-Manager for Kura Sushi USA, Inc. (Nasdaq:KRUS) in its $57 Million Follow-On</title>
      <pubDate>Wed, 18 Aug 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for RAPT Therapeutics, Inc. (NASDAQ: RAPT) in its $143.7 Million Follow-On Offering</title>
      <pubDate>Tue, 17 Aug 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Manager for Unicycive Therapeutics, Inc. (Nasdaq:UNCY) in its $25 Million IPO</title>
      <pubDate>Tue, 17 Aug 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for Immunic, Inc. (Nasdaq:IMUX) in its $45 Million Follow-On</title>
      <pubDate>Tue, 17 Aug 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Elemer Piros on the Potential of Psychedelics</title>
      <pubDate>Mon, 09 Aug 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Elemer Piros on the Psychedelic Market</title>
      <pubDate>Mon, 09 Aug 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners advised US Hybrid on its $65 Million acquisition by Ideanomics (Nasdaq:IDEX)</title>
      <pubDate>Mon, 02 Aug 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Financial Advisor for Torchlight Energy Resources Inc. (Nasdaq:TRCH) in its $1.9 Billion Merger with Metamaterial Inc.</title>
      <pubDate>Mon, 19 Jul 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Placement Agent for Torchlight Energy Resources (Nasdaq:TRCH) in its $137.5 Million ATM Program</title>
      <pubDate>Mon, 19 Jul 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Joint Lead-Manager for Riley Exploration Permian (NASDAQ:REPX) in its $50 Million Follow-On Offering</title>
      <pubDate>Mon, 19 Jul 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for Northern Oil &amp; Gas (NYSE American:NOG) in its $100.6 Million Follow-On Offering</title>
      <pubDate>Tue, 13 Jul 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Financial Advisor for KemPharm, Inc. (NASDAQ:KMPH) in its $39 Million Warrant Exchange Offering</title>
      <pubDate>Tue, 13 Jul 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for Celsius Holdings, Inc. (Nasdaq: CELH) in its $462 Million Follow-On</title>
      <pubDate>Mon, 12 Jul 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host a Virtual Healthcare Private Company Forum on June 28, 2021</title>
      <pubDate>Fri, 25 Jun 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Virtually Host 7th Annual Roth London Conference on June 21-23, 2021</title>
      <pubDate>Tue, 15 Jun 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Joint Book-Running Manager to Smith Micro Software, Inc. (NASDAQ: SMSI) in its $65.2 Million Follow-On Offering</title>
      <pubDate>Wed, 02 Jun 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Announces the Addition of John Boris to its Healthcare Investment Banking Team</title>
      <pubDate>Wed, 19 May 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Book-Running Manager for TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) in its $40 Million Follow-On Offering</title>
      <pubDate>Tue, 18 May 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners advises iLendingDIRECT on its acquisition by JC Flowers &amp; Co. LLC</title>
      <pubDate>Thu, 13 May 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>A psychedelic drug boom in mental health treatment comes closer to reality</title>
      <pubDate>Mon, 10 May 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Lead Placement Agent to Virtra Inc. (NASDAQ: VTSI) in its $18 Million Registered Direct Offering</title>
      <pubDate>Thu, 06 May 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Lead Placement Agent to Virtra Inc. (NASDAQ: VTSI) in its $18 Million Registered Direct Offerin</title>
      <pubDate>Wed, 28 Apr 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Joint Book-Running Manager for NV5 Global, Inc. (Nasdaq: NVEE) in its $172.5 Million Follow-On</title>
      <pubDate>Fri, 23 Apr 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Canada Announces the Addition of Michael Tait as Head of Origination</title>
      <pubDate>Wed, 14 Apr 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Announces the Addition of Ivan Saval, Managing Director, AgTech Investment Banking</title>
      <pubDate>Wed, 07 Apr 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Set to Host Upcoming Golden Cannabis Day Event on April 7, 2021</title>
      <pubDate>Wed, 31 Mar 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners advised StemoniX on its Merger with Cancer Genetics, Inc. (Nasdaq: CGIX)</title>
      <pubDate>Wed, 31 Mar 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Joint Book-Running Manager for AMMO, Inc. (Nasdaq: POWW) in its $115 Million Follow-On</title>
      <pubDate>Tue, 23 Mar 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Joint Book-Running Manager for A-Mark Precious Metals, Inc. (Nasdaq: AMRK) in its $80.5 Million Follow-On</title>
      <pubDate>Fri, 19 Mar 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) in its $14.5 Million Follow-On Offering</title>
      <pubDate>Tue, 16 Mar 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for Marker Therapeutics, Inc. (Nasdaq: MRKR) in its $56.5 Million Follow-On Offering</title>
      <pubDate>Mon, 15 Mar 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Placement Agent for Assertio Holdings, Inc. (NASDAQ: ASRT) in its $14 Million and $34.3 Million Registered Direct Offerings</title>
      <pubDate>Mon, 15 Mar 2021 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Joint Book-Running Manager for Phunware, Inc. (NASDAQ: PHUN) in its $26.5 Million Follow-On</title>
      <pubDate>Fri, 12 Mar 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners 33rd Annual Conference to be held Virtually March 15-17, 2021</title>
      <pubDate>Wed, 10 Mar 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners advised Tengasco, Inc. (NYSE:TGC) on its Merger with Riley Exploration Permian, LLC</title>
      <pubDate>Fri, 26 Feb 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Placement Agent for Bio-Path Holdings, Inc., (Nasdaq:BPTH) in its $13 Million Follow-On Offering</title>
      <pubDate>Thu, 18 Feb 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Placement Agent for NewAge, Inc. (Nasdaq: NBEV) in its $58 Million Private Placement</title>
      <pubDate>Tue, 16 Feb 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) in its $222.5 Million Follow-On</title>
      <pubDate>Tue, 16 Feb 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Placement Agent for InMed Pharmaceuticals Inc. (Nasdaq: INM) (TSX: IN) in its $4.5 Million PIPE Transaction</title>
      <pubDate>Tue, 16 Feb 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Joint Book-Running Manager for GT Biopharma, Inc. (NASDAQ: GTBP) in its $27.2 Million Follow-On</title>
      <pubDate>Tue, 16 Feb 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Financial Advisor to Esports Entertainment Group, Inc. (NASDAQ: GMBL) in its $30 Million Registered Direct Offering</title>
      <pubDate>Tue, 16 Feb 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Manager for Torchlight Energy Resources, Inc. (NASDAQ:TRCH) in its $27.6 Million Follow-On</title>
      <pubDate>Wed, 10 Feb 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Placement Agent &amp; Financial Advisor to Mountain Crest Acquisition Corp. and Playboy Enterprises, Inc.</title>
      <pubDate>Wed, 10 Feb 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners advises Hydrobuilder.com on its acquisition by Hydrobuilder Holdings LLC</title>
      <pubDate>Mon, 08 Feb 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH Capital Partners Acts as Co-Manager for CuriosityStream Inc. (NASDAQ: CURI) in its $100.9 Million Follow-On</title>
      <pubDate>Mon, 08 Feb 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for Northern Oil and Gas, Inc. (NYSE American: NOG) in its $140.2 Million Follow-On</title>
      <pubDate>Thu, 04 Feb 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for Moleculin Biotech, Inc. (Nasdaq: MBRX) in its $78 Million Follow-On</title>
      <pubDate>Wed, 03 Feb 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Sole Placement Agent for Applied DNA Sciences, Inc. (NASDAQ: APDN) in its $15 Million Registered Direct Offering</title>
      <pubDate>Thu, 28 Jan 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for Applied Genetic Technologies Corporation (Nasdaq: AGTC) in its $74.5 Million Follow-On</title>
      <pubDate>Thu, 28 Jan 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Joint Book-Running Manager for Agrify Corporation (NasdaqCM: AGFY) in its $62.1 Million IPO</title>
      <pubDate>Wed, 27 Jan 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for Merus N.V. (Nasdaq: MRUS) in its $138 Million Follow-On</title>
      <pubDate>Thu, 21 Jan 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH Capital Partners acts as Co-Placement Agent for Village Farms International, Inc. (NASDAQ: VFF) in its US$135 Million Registered Direct Offering</title>
      <pubDate>Wed, 20 Jan 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for Syros Pharmaceuticals (NASDAQ: SYRS) in its $75.6 Million Follow-On</title>
      <pubDate>Tue, 19 Jan 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Canada Announces the Addition of Braden Fletcher as President</title>
      <pubDate>Wed, 13 Jan 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Manager &amp; Sole Placement Agent for KemPharm, Inc. (NASDAQ: KMPH) in its $52.4 Million Follow-On &amp; $44 Million Warrant Exchange Transaction</title>
      <pubDate>Fri, 08 Jan 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Placement Agent for Clearside Biomedical, Inc. (NASDAQ:CLSD) in its $12 Million Registered Direct Offering</title>
      <pubDate>Wed, 06 Jan 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners advises Wireless Advanced Vehicle Electrification, Inc. on its acquisition by Ideanomics (NASDAQ: IDEX)</title>
      <pubDate>Tue, 05 Jan 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for Harpoon Therapeutics, Inc. (Nasdaq: HARP) in its $115 Million Follow-On</title>
      <pubDate>Mon, 04 Jan 2021 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager &amp; Placement Agent for Cellectar Biosciences, Inc. (NASDAQ: CLRB) in its $24.5 Million Follow-On &amp; concurrent $20.5 Million Private Placement</title>
      <pubDate>Wed, 23 Dec 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Book-Running Manager for Asure Software, Inc. (NASDAQ: ASUR) in its $18.9 Million Follow-On</title>
      <pubDate>Wed, 23 Dec 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Sustain SoCal Sees Boom in Clean Tech</title>
      <pubDate>Mon, 14 Dec 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Sole Book-Running Manager for Vivos Therapeutics, Inc. (VVOS) in its $24.2 Million IPO</title>
      <pubDate>Thu, 10 Dec 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Joint Book-Running Manager for Pixelworks, Inc. (Nasdaq: PXLW) in its $13.8 Million Follow-On</title>
      <pubDate>Thu, 10 Dec 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Co-Manager for LivePerson, Inc. (NASDAQ: LPSN) in its $517.5 Million Convertible Senior Notes Offering</title>
      <pubDate>Thu, 10 Dec 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Joint Book-Running Manager for Delcath Systems, Inc. (Nasdaq: DCTH) in its US$22.2 Million Follow-On</title>
      <pubDate>Wed, 09 Dec 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Co-Manager for Atara Biotherapeutics, Inc. (Nasdaq: ATRA) in its $175 Million Follow-On</title>
      <pubDate>Tue, 08 Dec 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host Consumer Virtual Event December 9-11, 2020</title>
      <pubDate>Mon, 07 Dec 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host Consumer Virtual Event December 9-11, 2020</title>
      <pubDate>Mon, 07 Dec 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Announces the Addition of Benjamin Bowen, Ph.D. to its Healthcare Investment Banking Team</title>
      <pubDate>Thu, 03 Dec 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Co-Manager for Cambium Networks Corporation (Nasdaq: CMBM) in its $70 Million Secondary Follow-On</title>
      <pubDate>Thu, 03 Dec 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners and Sustain SoCal to Host Sustainability Virtual Private Capital Event on December 2-3, 2020</title>
      <pubDate>Mon, 30 Nov 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth SPAC Forming $1.2B Recyling Biz</title>
      <pubDate>Mon, 30 Nov 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>DEAL of the YEAR ● MIDDLE MARKETS (Size Range: Above $250 - Below $500 million.) WINNER: NV5 Global acquires Geospatial including Quantum Spatial from Arlington Capital Partners. Deal Team Winner: Loeb &amp; Loeb, LLP, legal team and ROTH Capital investment bankers advised the Florida-based NV5 Global, a provider of professional, technical engineering and consulting solutions.</title>
      <pubDate>Wed, 18 Nov 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Placement Agent for a $6.9 Million Secondary Registered Direct: Lung Therapeutics sold shares of TFF Pharmaceuticals</title>
      <pubDate>Thu, 12 Nov 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acted as Sole Book-Running Manager for InMed Pharmaceuticals Inc. (NASDAQ: INM) in its US$8 Million Follow-On</title>
      <pubDate>Thu, 12 Nov 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host Technology Virtual Event November 11-12, 2020</title>
      <pubDate>Tue, 10 Nov 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH Capital Partners Acts as Sole Book-Running Manager for Reed&apos;s Inc. (Nasdaq: REED) in its $12.1 Million Follow-On</title>
      <pubDate>Mon, 09 Nov 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Co-Manager for Turning Point Therapeutics, Inc. (Nasdaq: TPTX) in its $460 Million Follow-On</title>
      <pubDate>Mon, 26 Oct 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Co-Manager for Replimune Group, Inc. (Nasdaq: REPL) in its $287.5 Million Follow-On</title>
      <pubDate>Thu, 22 Oct 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners announces the addition of Hershel Gerson, Managing Director, Co-Head of Consumer Investment Banking</title>
      <pubDate>Thu, 22 Oct 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Financial Advisor for ThinkIQ in its $11.6 Million Series A Financing</title>
      <pubDate>Tue, 20 Oct 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners, NGO Sustainability with the Governments of Portugal, Kenya, and Sri Lanka Hosted a Virtual Side Event</title>
      <pubDate>Mon, 19 Oct 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>2020 Celebration of Abilities Awards Program</title>
      <pubDate>Sat, 17 Oct 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Bio Investor Forum Digital has selected, Fireside Chat with Nisa Leung, Qiming Venture Partners and James Antonopoulos, ROTH Capital Partners on Cross-Pacific Investment Perspectives, as one of the &quot;Best of Bio&quot; panels from the event</title>
      <pubDate>Wed, 14 Oct 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Sole Book-Running Manager for TransAct Technologies Incorporated (Nasdaq: TACT) in its $10 Million Follow-On</title>
      <pubDate>Wed, 14 Oct 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Co-Manager for fuboTV, Inc. (NYSE : FUBO) in its $183 Million Follow-On</title>
      <pubDate>Thu, 08 Oct 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Co-Manager for Mission Produce (NASDAQ: AVO) in its $96 Million IPO</title>
      <pubDate>Wed, 30 Sep 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Co-Manager for Mission Produce (NASDAQ: AVO) in its $96 Million IPO</title>
      <pubDate>Wed, 30 Sep 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH Capital Partners acts as Co-Manager for Laird Superfood, Inc. (NYSE: LSF) in its $67 Million IPO</title>
      <pubDate>Fri, 25 Sep 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH Capital Partners acts as Sole Manager for Loop Industries, Inc. (NASDAQ: LOOP) in its $26.6 Million Follow-On</title>
      <pubDate>Mon, 21 Sep 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Co-Manager for Medallia, Inc. (NYSE:MDLA) in its $575 Million Convertible Senior Notes Offering</title>
      <pubDate>Mon, 14 Sep 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Co-Manager for Humanigen, Inc. (NASDAQ:HGEN) in its $78.2 Million Follow-On</title>
      <pubDate>Mon, 14 Sep 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Sole Placement Agent for Seelos Therapeutics, Inc. (Nasdaq: SEEL) in its $7 Million Registered Direct</title>
      <pubDate>Fri, 04 Sep 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Sole Book-Running Manager for Centrus Energy Corp. (NYSE American: LEU) in its $23.5 Million Follow-On</title>
      <pubDate>Thu, 03 Sep 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Sole Book-Running Manager for CohBar, Inc. (NASDAQ: CWBR) in its $15 Million Follow-On</title>
      <pubDate>Tue, 01 Sep 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Joint Book-Running Manager for Flux Power Holdings, Inc. (NASDAQ CM: FLUX) in its $12.4 Million Follow-On</title>
      <pubDate>Fri, 28 Aug 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners advises DSP Group, Inc. (NASDAQ: DSPG) on its acquisition of SoundChip SA</title>
      <pubDate>Tue, 25 Aug 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Sole Manager for Fathom Holdings Inc. (NASDAQ: FTHM) in its $34.3 Million IPO</title>
      <pubDate>Mon, 24 Aug 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Sole Placement Agent for MediPharm Labs Corp. (TSX: LABS) in its CAD$37.8 Million Private Placement</title>
      <pubDate>Thu, 20 Aug 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for Quhuo Limited (NASDAQ: QH) in its $37.9 Million IPO</title>
      <pubDate>Tue, 18 Aug 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH Capital Partners acts as Sole Book-Running Manager for Rimini Street, Inc. (Nasdaq: RMNI) in its $27.5 Million Follow-On</title>
      <pubDate>Fri, 14 Aug 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Placement Agent for Tellurian, Inc. (NASDAQ: TELL) in its $35 Million Registered Direct Offering</title>
      <pubDate>Tue, 04 Aug 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Atreca, Inc. (Nasdaq: BCEL) in its $125 Million Follow-On</title>
      <pubDate>Thu, 23 Jul 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Altimmune, Inc. (Nasdaq: ALT) in its $132.3 Million Follow-On</title>
      <pubDate>Wed, 22 Jul 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Inventiva S.A. (Nasdaq: IVA &amp; Euronext Paris: IVA) in its $107.7 Million U.S. IPO</title>
      <pubDate>Tue, 21 Jul 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH Capital Partners Announces the Addition of Elemer Piros, Ph.D. to its Healthcare</title>
      <pubDate>Wed, 08 Jul 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Co-Manager for CRISPR Therapeutics (Nasdaq:CRSP) in its $517.5 Million Follow-On</title>
      <pubDate>Tue, 07 Jul 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as a Lead Manager for Translate Bio, Inc. (Nasdaq: TBIO) in its $275.2 Million Follow-On</title>
      <pubDate>Mon, 06 Jul 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Placement Agent for ElectraMeccanica Vehicles Corp. (NASDAQ: SOLO) in its $20 Million Registered Direct</title>
      <pubDate>Wed, 01 Jul 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Placement Agent &amp; Financial Advisor for Allied Esports Entertainment (NASDAQ: AESE) in its $9 Million Senior Secured Convertible Promissory Notes Refinance</title>
      <pubDate>Fri, 26 Jun 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Lead Placement Agent for Immunic, Inc. (Nasdaq: IMUX) in its $25 Million Follow-On</title>
      <pubDate>Mon, 22 Jun 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Financial Advisor for Vutiliti in its $11.75 Million Private Placement</title>
      <pubDate>Fri, 19 Jun 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Financial Advisor for Lumitron Technologies, Inc. (Private) in its $34 Million Private Placement</title>
      <pubDate>Fri, 12 Jun 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Lead Manager for Cellectar Biosciences, Inc. (NASDAQ: CLRB) in its $20 Million Follow-On</title>
      <pubDate>Wed, 10 Jun 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Co-Manager for Five9, Inc. (NASDAQ: FIVN) in its $747.5 Million Convertible Senior Notes Offering</title>
      <pubDate>Tue, 09 Jun 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Lead Manager for Adaptimmune Therapeutics plc (Nasdaq: ADAP) in its $259.3 Million Follow-On</title>
      <pubDate>Mon, 08 Jun 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Lead Manager for Sequans Communications S.A. (NYSE: SQNS) in its $25 Million Follow-On</title>
      <pubDate>Fri, 05 Jun 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Lead Manager for Sequans Communications S.A. (NYSE: SQNS) in its $25 Million Follow-On</title>
      <pubDate>Tue, 02 Jun 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Axcella Health (Nasdaq: AXLA) in its $60.1 Million Follow-On</title>
      <pubDate>Tue, 26 May 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Compass Diversified Holdings (NYSE: CODI) in its $88 million Follow-On</title>
      <pubDate>Fri, 15 May 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for Delcath Systems, Inc. (NASDAQ: DCTH) in its $22 Million Follow-On</title>
      <pubDate>Thu, 14 May 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Placement Agent for Tellurian, Inc. (NASDAQ: TELL) in its $56 Million Registered Direct Note Offering</title>
      <pubDate>Thu, 07 May 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Placement Agent for Immunic, Inc. (Nasdaq: IMUX) in its $15 Million Registered Direct</title>
      <pubDate>Wed, 06 May 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Lead Placement Agent for Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) In its $20 Million Follow-On</title>
      <pubDate>Tue, 05 May 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Arcturus Therapeutics Holdings, Inc. (NASDAQ: ARCT) in its $80.5 Million Follow-On</title>
      <pubDate>Mon, 04 May 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Manager for Reed’s Inc. (Nasdaq: REED) in its $5.8 Million Follow-On</title>
      <pubDate>Fri, 24 Apr 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Crinetics Pharmaceuticals (Nasdaq: CRNX) in its $115.1 Million Follow-On</title>
      <pubDate>Thu, 23 Apr 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Lead Manager for Bionano Genomics (NASDAQ: BNGO) in its $18 Million Follow-On</title>
      <pubDate>Mon, 20 Apr 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Financial Advisor to Boardriders on its sale of Xcel to ZG Holdings</title>
      <pubDate>Thu, 16 Apr 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Technology &amp; Healthcare Teams Recognized for M&amp;A transactions</title>
      <pubDate>Fri, 20 Mar 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Virtual Conference | Thank You for Your Support</title>
      <pubDate>Thu, 19 Mar 2020 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Announces the Addition of George Kelly and Matthew Koranda to its Consumer Research Group</title>
      <pubDate>Wed, 04 Mar 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Placement Agent for Lipocine Inc. (NASDAQ:LPCN) in its $6 Million Registered Direct</title>
      <pubDate>Mon, 02 Mar 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners advises NV5 on its Acquisition of Quantum Spatial</title>
      <pubDate>Wed, 19 Feb 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Applied Genetic Technologies Corporation (Nasdaq: AGTC) in its $37.4 Million Follow-On</title>
      <pubDate>Tue, 18 Feb 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partnersacts as Sole Book-Running Manager for Myomo, Inc. (NYSE American: MYO) in its $15 Million Follow-On</title>
      <pubDate>Fri, 14 Feb 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Lead Manager for aTyr Pharma, Inc. (Nasdaq: LIFE) in its $18 Million Follow-On</title>
      <pubDate>Wed, 12 Feb 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Sponsor &amp; Speak at BIO CEO Conference</title>
      <pubDate>Wed, 05 Feb 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Manager for Global Water Resources, Inc. (NASDAQ: GWRS) in its $12.5 Million Follow-On</title>
      <pubDate>Mon, 03 Feb 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Adaptimmune Therapeutics plc (Nasdaq: ADAP) in its $84 Million Follow-On</title>
      <pubDate>Wed, 29 Jan 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Years after passing, Duane Roth&apos;s legacy lives on through family and philanthropy</title>
      <pubDate>Tue, 28 Jan 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Releases its 2020 Millennial Survey</title>
      <pubDate>Wed, 22 Jan 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB) in its $50 Million Follow-On</title>
      <pubDate>Fri, 17 Jan 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) in its $48 Million Follow-On</title>
      <pubDate>Thu, 16 Jan 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Bolsters its Healthcare Franchise with Key Hires</title>
      <pubDate>Fri, 10 Jan 2020 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as U.S. Placement Agent for Imugene Limited (ASX: IMU) in its A$24.6 Million PIPE</title>
      <pubDate>Mon, 23 Dec 2019 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Forty Seven, Inc. (Nasdaq: FTSV) in its $195.6 Million Follow-On</title>
      <pubDate>Mon, 23 Dec 2019 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Financial Advisor to eyeBrain Medical, Inc. Series D Financing</title>
      <pubDate>Thu, 19 Dec 2019 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Financial Advisor to CorneaGen Series B Financing and Convertible Debt Facility</title>
      <pubDate>Fri, 13 Dec 2019 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Sustaining Clean Tech</title>
      <pubDate>Tue, 10 Dec 2019 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>OTH Capital Partners Acts as Financial Advisor to Asure Software (NASDAQ:ASUR)</title>
      <pubDate>Tue, 10 Dec 2019 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>https://d1io3yog0oux5.cloudfront.net/roth/files/marketing/email_blasts/SITM_Nov2019.htm</title>
      <pubDate>Wed, 04 Dec 2019 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for CRISPR Therapeutics (Nasdaq:CRSP) in its $315.2 Million Follow-O</title>
      <pubDate>Tue, 03 Dec 2019 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for Giga-tronics Incorporated (OTCQB: GIGA) in its $2.6 Million Follow-On</title>
      <pubDate>Mon, 02 Dec 2019 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners and Sustain SoCal to Host Cleantech Private Capital Day v2 in Irvine, California on December 4, 2019</title>
      <pubDate>Mon, 25 Nov 2019 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title> November 25, 2019 Roth Capital Partners	Roth Capital Partners Acts as Sole Placement Agent for Lipocine, Inc. (NASDAQ: LPCN) in its $6 Million Follow-On</title>
      <pubDate>Mon, 25 Nov 2019 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Strong Consumer Spending To Support Solid Holiday Season, Forecasters Said</title>
      <pubDate>Thu, 21 Nov 2019 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Replimune Group, Inc. (Nasdaq: REPL) in its $80 Million Follow-On</title>
      <pubDate>Wed, 20 Nov 2019 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Merus N.V. (Nasdaq: MRUS) in its $79.2 Million Follow-On</title>
      <pubDate>Tue, 12 Nov 2019 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host SiC and GaN Day in New York City, NY on November 21, 2019</title>
      <pubDate>Fri, 08 Nov 2019 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host Technology &amp; New Industrials Day in New York City, NY on November 13, 2019</title>
      <pubDate>Mon, 04 Nov 2019 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>2019 Forty Under 40 in the Oil &amp; Gas Industry</title>
      <pubDate>Fri, 01 Nov 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Soleno Therapeutics, Inc. (SLNO) in its $15.4 Million Follow-On</title>
      <pubDate>Fri, 01 Nov 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Manager for Reed‚Äôs Inc. (Nasdaq: REED) in its $7 Million Follow-On</title>
      <pubDate>Thu, 31 Oct 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners, NGO Sustainability and Republic of Slovenia to Host Climate Action: Latest Business Technologies for Meeting the SDGs October 4, 2019 in New York City</title>
      <pubDate>Mon, 30 Sep 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>SPI19 was a powerful moment: Smart Energy Week 2019</title>
      <pubDate>Mon, 30 Sep 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Advisor to OnForce Solar, Inc. in its acquisition by 174 Power Global</title>
      <pubDate>Tue, 24 Sep 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Advises SPY on its Merger with Bollé Brands</title>
      <pubDate>Mon, 16 Sep 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host 7th Annual Solar &amp; Storage Symposium at Solar Power International (SPI 19)</title>
      <pubDate>Mon, 09 Sep 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Placement Agent for Seelos Therapeutics, Inc. (Nasdaq: SEEL) in its $6.7 Million Registered Direct</title>
      <pubDate>Wed, 28 Aug 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Announces the Addition of Zegbeh Jallah, Ph.D. to its Healthcare Research Team</title>
      <pubDate>Tue, 27 Aug 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for
ACM Research, Inc. (NASDAQ: ACMR)
in its $25 Million Follow-On</title>
      <pubDate>Thu, 22 Aug 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Sunnova Energy International, Inc. (NYSE: NOVA) in its $168 Million IPO</title>
      <pubDate>Thu, 15 Aug 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Financial Advisor to Grenco Science Series A Financing</title>
      <pubDate>Tue, 13 Aug 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Lead Manager For Kura Sushi USA, Inc. (Nasdaq: KRUS) in its $46.7 Million IPO</title>
      <pubDate>Wed, 07 Aug 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Chiasma, Inc. (Nasdaq: CHMA) in its $55 Million Follow-On</title>
      <pubDate>Mon, 05 Aug 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Placement Agent for Delcath Systems, Inc. (OTCPK: DCTH) in its $20 Million PIPE</title>
      <pubDate>Wed, 31 Jul 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Amarin Corporation plc (Nasdaq: AMRN) in its $460 Million Follow-On</title>
      <pubDate>Tue, 30 Jul 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Forty Seven, Inc. (Nasdaq: FTSV) in its $86.3 Million Follow-On</title>
      <pubDate>Mon, 29 Jul 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) in its $75 Million IPO</title>
      <pubDate>Fri, 26 Jul 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as a Co-Manager for Medallia, Inc. (NYSE: MDLA) in its $374.3 Million IPO</title>
      <pubDate>Thu, 25 Jul 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Financial Advisor for the Merger between NeuBase Therapeutics, Inc. (NBSE) &amp; Ohr Pharmaceutical, Inc. (OHRP)</title>
      <pubDate>Wed, 24 Jul 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for ArQule, Inc. (Nasdaq:ARQL) in its $103.7 Million Follow-On</title>
      <pubDate>Fri, 28 Jun 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Lead Manager for Akero Therapeutics, Inc. (NASDAQ: AKRO) in its $105.8 Million IPO</title>
      <pubDate>Wed, 26 Jun 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Lead Placement Agent For ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV) in its $15.6 Million Follow-On</title>
      <pubDate>Tue, 25 Jun 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for SharpSpring, Inc. (Nasdaq: SHSP) in its $26.7 Million Secondary Offering</title>
      <pubDate>Mon, 24 Jun 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Scores TD With NFL QB Rodgers</title>
      <pubDate>Fri, 14 Jun 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Manager for Charles &amp; Colvard, Ltd. (Nasdaq: CTHR) in its $10 Million Follow-On</title>
      <pubDate>Thu, 13 Jun 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host 5th Annual ROTH London Conference on June 17- 19, 2019 in London, UK</title>
      <pubDate>Wed, 12 Jun 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Aaron Rodgers Launches $50 Million Venture Capital Fund with Roth Capital Partners</title>
      <pubDate>Wed, 05 Jun 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for InterDigital (IDCC) in its $400 Million Senior Convertible Notes Offering</title>
      <pubDate>Tue, 04 Jun 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for The Lovesac Company (Nasdaq: LOVE) in its $103.5 Million Follow-On</title>
      <pubDate>Mon, 03 Jun 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as U.S. Placement Agent for Prescient Therapeutics Limited (ASX: PTX) in its $7 Million AUD PIPE</title>
      <pubDate>Fri, 31 May 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>6th Annual ROTH China Solar Tour to be Held in Conjunction with SNEC Power Expo in Shanghai June 3-6, 2019</title>
      <pubDate>Thu, 23 May 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>
 

Roth Capital Partners Acts as Sole Placement Agent
for Cellectar Biosciences, Inc. (NASDAQ: CLRB)
in its $10 Million Financing</title>
      <pubDate>Thu, 23 May 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for Jiayin Group Inc. (Nasdaq: JFIN) in its $42.3 Million IPO</title>
      <pubDate>Tue, 21 May 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for JinkoSolar Holding Co., Ltd. (NYSE: JKS) in its $74.8 Million Follow-On</title>
      <pubDate>Tue, 21 May 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Co-Manager for Gogo Inc. (NASDAQ: GOGO) in its $925 Million 9.875% Senior Secured Notes Offering</title>
      <pubDate>Wed, 15 May 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH Conference makes Southern California&apos;s Top 100 Events for 2019</title>
      <pubDate>Tue, 14 May 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Mustang Bio, Inc. (NASDAQ: MBIO) in its $31.6 Million Follow-On</title>
      <pubDate>Fri, 10 May 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Advisor to Pointer Telocation Ltd. (Nasdaq: PNTR; TASE: PNTR) in its acquisition by I.D. Systems, Inc. (NASDAQ: IDSY)</title>
      <pubDate>Sun, 28 Apr 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Lead Manager for Bionano Genomics, Inc. (Nasdaq: BNGO) in its $18 Million Follow-On</title>
      <pubDate>Thu, 25 Apr 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for BioDelivery Sciences International, Inc. (Nasdaq: BDSI) in its $60 Million Follow-On</title>
      <pubDate>Tue, 23 Apr 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Manager for
Quest Resource Holding Corporation (NASDAQ: QRHC)
in its $6.5 Million Secondary Offering</title>
      <pubDate>Mon, 22 Apr 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Advisor to Yanmar America Corporation in its acquisition of ASV Holdings, Inc. (Nasdaq: ASV)</title>
      <pubDate>Sun, 21 Apr 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for Dar√© Bioscience, Inc. (NASDAQ:DARE) in its $5.8 Million Follow-On</title>
      <pubDate>Thu, 18 Apr 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Analyst says cannabis industry not as bad as people think</title>
      <pubDate>Mon, 15 Apr 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Lead Placement Agent for Soliton, Inc. (NASDAQ: SOLY) in its $6.3 Million Private Placement</title>
      <pubDate>Mon, 15 Apr 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Syros Pharmaceuticals (NASDAQ: SYRS) in its $70 Million Follow-On</title>
      <pubDate>Mon, 15 Apr 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager
for Chiasma, Inc. (Nasdaq: CHMA) in its
$34.5 Million Follow-On</title>
      <pubDate>Thu, 11 Apr 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Co-Manager for Adesto Technologies (Nasdaq: IOTS) in its $80.5 Million Senior Convertible Notes Offering</title>
      <pubDate>Tue, 09 Apr 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for GENFIT SA (Nasdaq:GNFT) in its $155.4 Million IPO</title>
      <pubDate>Mon, 08 Apr 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for CymaBay Therapeutics, Inc. (Nasdaq: CBAY) in its $115 Million Follow-On</title>
      <pubDate>Fri, 05 Apr 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>How This Financial Conference Avoids Being Stuffy</title>
      <pubDate>Thu, 04 Apr 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Lead Placement Agent for Electra Meccanica Vehicles Corp. (NASDAQ: SOLO) in its $12 Million Registered Direct Offering</title>
      <pubDate>Wed, 03 Apr 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title> BizBash	31st Annual ROTH Conference | Ranked in the Top 100 Events in the United States in 2019 | #5 Business &amp; Financial Industry Event</title>
      <pubDate>Mon, 01 Apr 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Placement Agent for BioPharmX Corporation (NYSE American: BPMX) in its $3.9 Million Registered Direct</title>
      <pubDate>Thu, 28 Mar 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Announces the Promotion of Yasmeen Rahimi, Ph.D.</title>
      <pubDate>Wed, 27 Mar 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Placement Agent for Altimmune, Inc. (Nasdaq: ALT) in its $14 Million Registered Direct</title>
      <pubDate>Fri, 22 Mar 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host ROTH Battle of the NASH Thrones Spring Investor Conference in New York City on March 28, 2019</title>
      <pubDate>Thu, 21 Mar 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners | 31st Annual Growth Stock Conference to be held March 17-19, 2019</title>
      <pubDate>Mon, 11 Mar 2019 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for Reed&apos;s Inc. (REED) in its $16.2 Million Follow-On</title>
      <pubDate>Thu, 21 Feb 2019 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Announces the Addition of Charles ‚ÄúTony‚Äù Butler, Ph.D.
to its Healthcare Research Team</title>
      <pubDate>Wed, 20 Feb 2019 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Placement Agent for Seelos Therapeutics, Inc. (Nasdaq: SEEL) in its $18 Million PIPE</title>
      <pubDate>Thu, 07 Feb 2019 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners advises S.M.R.E. SpA in its sale to SolarEdge Technologies, Inc.</title>
      <pubDate>Tue, 29 Jan 2019 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Financial Advisor to TekWorks, Inc. in its merger with Paladin Technologies, Inc.</title>
      <pubDate>Thu, 10 Jan 2019 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host 6th Annual ROTH New Industrials Corporate Access Day in New York City</title>
      <pubDate>Tue, 27 Nov 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for The Lovesac Company (Nasdaq:LOVE) in its $42.2 Million Secondary Offering</title>
      <pubDate>Mon, 19 Nov 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for New Age Beverages Corporation (NASDAQ: NBEV) in its $52 Million Follow-On</title>
      <pubDate>Fri, 16 Nov 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager
For CNFinance Holdings Limited (NYSE: CNF)
in its $52 Million IPO</title>
      <pubDate>Thu, 15 Nov 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Releases its 2018-2019 Millennial Survey</title>
      <pubDate>Mon, 12 Nov 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as U.S. Placement Agent for Oryzon Genomics, S.A. (MAD: ORY) in its ‚Ç¨13 Million PIPE</title>
      <pubDate>Mon, 05 Nov 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Announces the Addition of Jerry Isaacson, Ph.D. to its Healthcare Research Team</title>
      <pubDate>Mon, 05 Nov 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host 4th Annual Technology Corporate Access Day in New York City, NY on November 14, 2018</title>
      <pubDate>Thu, 01 Nov 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Sole Book-Running Manager for Atomera Incorporated (Nasdaq: ATOM) in its $12.5 Million Follow-On</title>
      <pubDate>Thu, 18 Oct 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Investors Hear Pitches From Clean-Tech Companie</title>
      <pubDate>Mon, 15 Oct 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for Willdan Group, Inc. (NASDAQ: WLDN) in its $60.4 Million Follow-On</title>
      <pubDate>Fri, 12 Oct 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for KemPharm, Inc. (NASDAQ:KMPH) in its $25 Million Follow-On</title>
      <pubDate>Fri, 12 Oct 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Manager &amp; Sole Placement Agent for Altimmune, Inc. (Nasdaq: ALT) in its $41.9 Million in Funding</title>
      <pubDate>Thu, 11 Oct 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host ROTH Battle of the NASH Thrones Investor Conference in New York City on October 17, 2018</title>
      <pubDate>Tue, 02 Oct 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Sensus Healthcare, Inc. (Nasdaq: SRTS) in its $15 Million Follow-On</title>
      <pubDate>Wed, 19 Sep 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners, Sustain OC, CMA and Procopio to Host Cleantech Private Capital Day at The Cove at UC Irvine Applied Innovation in Irvine, CA on October 3, 2018</title>
      <pubDate>Tue, 18 Sep 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Tilly‚Äôs, Inc. (NYSE:TLYS) in its $117 Million Secondary Offering</title>
      <pubDate>Mon, 17 Sep 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host 6th Annual Solar &amp; Storage Symposium at Solar Power International (SPI 18)</title>
      <pubDate>Wed, 12 Sep 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) in its $78.2 Million Follow-On</title>
      <pubDate>Tue, 11 Sep 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for New Age Beverages Corporation (NASDAQ: NBEV) in its $11.8 Million Follow-On</title>
      <pubDate>Wed, 29 Aug 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for Bionano Genomics, Inc. (Nasdaq: BNGOU) in its $20.6 Million IPO</title>
      <pubDate>Fri, 24 Aug 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host ROTH Internet of Things Corporate Access Day in San Francisco, Calif., on September 5, 2018</title>
      <pubDate>Tue, 21 Aug 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Maxwell Technologies, Inc. (Nasdaq: MXWL) in its $24.7 Million Follow-On</title>
      <pubDate>Wed, 15 Aug 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for NV5 Global, Inc. (NASDAQ: NVEE) in its $115 Million Follow-On</title>
      <pubDate>Tue, 14 Aug 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Acer Therapeutics Inc. (Nasdaq: ACER) in its $46 Million Follow-On</title>
      <pubDate>Tue, 07 Aug 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Manager
for Global Water Resources, Inc. (Nasdaq:GWRS)
in its $15.9 Million Follow-On</title>
      <pubDate>Wed, 01 Aug 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Lead Manager for Tilray, Inc. (Nasdaq: TLRY) in its $176 Million IPO</title>
      <pubDate>Tue, 31 Jul 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Financial Advisor to GrubMarket in its $32 Million Private Placement</title>
      <pubDate>Fri, 20 Jul 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Joint Book-Running Manager for Adesto Technologies (Nasdaq: IOTS) in its $46.2 Million Follow-On</title>
      <pubDate>Thu, 19 Jul 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for ArQule (Nasdaq: ARQL) in its $69.6 Million Follow-On</title>
      <pubDate>Wed, 18 Jul 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for Profire Energy, Inc. (Nasdaq:PFIE) in its $28 Million Secondary Public Offering</title>
      <pubDate>Tue, 10 Jul 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for The Lovesac Company (Nasdaq: LOVE) in its $64.4 Million IPO</title>
      <pubDate>Mon, 09 Jul 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Lead Manager for Limoneira Company (Nasdaq:LMNR) in its $69 Million Follow-On</title>
      <pubDate>Thu, 28 Jun 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners acts as Joint Book-Running Manager for Veritone, Inc. (Nasdaq: VERI) in its $35.2 Million Follow-On</title>
      <pubDate>Wed, 27 Jun 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Lead Manager for Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) in its $75 Million Follow-On</title>
      <pubDate>Mon, 25 Jun 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for Asure Software, Inc. (NASDAQ:ASUR) in its $50 Million Follow-On</title>
      <pubDate>Tue, 19 Jun 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host Precious Metals Corporate Access Day in New York on June 26, 2018</title>
      <pubDate>Mon, 18 Jun 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Viking Therapeutics, Inc. (NASDAQ: VKTX) in its $77.6 Million Follow-On</title>
      <pubDate>Wed, 13 Jun 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Madrigal Pharmaceuticals, Inc. (Nasdaq:MDGL) in its $411 Million Follow-On</title>
      <pubDate>Tue, 12 Jun 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH Conference in Laguna Niguel brings out big musical acts, raises funds</title>
      <pubDate>Tue, 12 Jun 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to host ROTH London Conference June 19-20, 2018</title>
      <pubDate>Mon, 11 Jun 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for BG Staffing, Inc. (NYSE American: BGSF) in its $23 Million Follow-On</title>
      <pubDate>Fri, 01 Jun 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Evofem Biosciences, Inc. (NASDAQ: EVFM) in its $40 Million Follow-On</title>
      <pubDate>Thu, 31 May 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)
in its $750 Million Convertible Senior Notes Offering</title>
      <pubDate>Wed, 30 May 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Financial Advisor and Placement Agent to Adesto Technologies (NASDAQ:IOTS)</title>
      <pubDate>Wed, 16 May 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title> 5th Annual ROTH China Solar Tour to be Held in Conjunction with SNEC Power Expo in Shanghai May 28-31, 2018
ROTH Investor Tour to Meet with ~ 20 Solar Power &amp; Clean Technology Companies on Booth Tours and Facility Visits</title>
      <pubDate>Tue, 15 May 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners advises U.S. Geothermal, Inc. (NYSE:HTM) in its sale to Ormat Technologies, Inc. (NYSE:ORA)</title>
      <pubDate>Mon, 30 Apr 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Manager for Aspen Group, Inc. (NASDAQ: ASPU) in its $23 Million Follow-On</title>
      <pubDate>Wed, 25 Apr 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for Torchlight Energy Resources, Inc (NASDAQ:TRCH) in its $6.6 Million Follow-On
</title>
      <pubDate>Tue, 24 Apr 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Film on Chinese Reverse Mergers Hits Roth Capital | Review: &quot;China Hustle&quot; incorrect on key points</title>
      <pubDate>Mon, 23 Apr 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>The Venture Banker | After 26 Years, Byron Roth Keeps Adapting and Embracing Risk</title>
      <pubDate>Mon, 23 Apr 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Daqo New Energy Corp. (NYSE: DQ) in its $110 Million Follow-On</title>
      <pubDate>Thu, 19 Apr 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for GlycoMimetics, Inc. (GLYC) in its $137 Million Follow-On</title>
      <pubDate>Wed, 28 Mar 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Placement Agent for EnviroLeach in its C$10 Million Private Placement
</title>
      <pubDate>Wed, 28 Mar 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners advises EdgePower, Inc. in its sale to Just Energy Group, Inc.</title>
      <pubDate>Thu, 22 Mar 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Aimmune Therapeutics, Inc. (NASDAQ:AIMT) in its $202.4 Million Follow-On
</title>
      <pubDate>Tue, 20 Mar 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH Recaps 30th Annual ROTH Conference</title>
      <pubDate>Tue, 20 Mar 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH Conference Draws 4,710 People
Finance: Popular event highlights AI, Blockchain and Cannabis</title>
      <pubDate>Fri, 16 Mar 2018 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Aimmune Therapeutics, Inc. (NASDAQ:AIMT) in its $202.4 Million Follow-On</title>
      <pubDate>Wed, 07 Mar 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners 30th Annual Growth Stock Conference to be held March 11-14, 2018</title>
      <pubDate>Mon, 05 Mar 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Ring Energy, Inc. (NYSE:REI) in its $86.3 Million Follow-On</title>
      <pubDate>Fri, 02 Mar 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for One Stop Systems, Inc. (NASDAQ:OSS) in its $19.5 Million IPO</title>
      <pubDate>Thu, 01 Mar 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Avid Bioservices, Inc. (CDMO) in its $23.1 Million Follow-On
</title>
      <pubDate>Wed, 28 Feb 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Placement Agent for Inpixon (NASDAQ:INPX) Offerings with Gross Proceeds Totaling $21.2 Million</title>
      <pubDate>Wed, 28 Feb 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Placement Agent for Moleculin Biotech, Inc., (MBRX) in its $9 Million Registered Direct
</title>
      <pubDate>Thu, 22 Feb 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Manager for Dar√© Bioscience, Inc. (DARE) in its $10.25 Million Follow-On</title>
      <pubDate>Wed, 21 Feb 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Placement Agent for Delcath Systems, Inc. (DCTH) in its $5 Million Follow-On</title>
      <pubDate>Tue, 20 Feb 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Placement Agent for My Size, Inc. (NASDAQ: MYSZ; TASE: MYSZ) Offerings with Gross Proceeds Totaling $9.7 Million</title>
      <pubDate>Fri, 16 Feb 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Financial Advisor for Avid Bioservices (CDMO)</title>
      <pubDate>Thu, 15 Feb 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Lead Manager for Gemphire Therapeutics Inc. (NASDAQ:GEMP) in its $22 Million Follow-On</title>
      <pubDate>Tue, 13 Feb 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Viking Therapeutics, Inc. (VKTX) in its $63.3 Million Follow-On</title>
      <pubDate>Wed, 07 Feb 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for CymaBay Therapeutics, Inc. (Nasdaq:CBAY) in its $144 Million Follow-On</title>
      <pubDate>Tue, 06 Feb 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Lead Placement Agent for Q BioMed Inc. (OTCQB: QBIO) in its $5.5 Million Follow-On</title>
      <pubDate>Fri, 02 Feb 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Financial Advisor to GT Biopharma Inc. (OTCQB: GTBP and Euronext Paris: GTBP.PA) in its $7.1 Million Private Placement</title>
      <pubDate>Thu, 01 Feb 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Albireo Pharma, Inc. (ALBO) in its $74.7 Million Follow-On</title>
      <pubDate>Wed, 31 Jan 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for Eyenovia Inc. (EYEN) in its $27.3 Million IPO</title>
      <pubDate>Tue, 30 Jan 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Stemline Therapeutics, Inc. (STML), in its $59.6 Million Follow-On</title>
      <pubDate>Mon, 29 Jan 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Placement Agent for Radisys Corporation (NASDAQ: RSYS) in its $17 Million Senior Notes Financing</title>
      <pubDate>Tue, 09 Jan 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Healthcare Team | 2017 Year in Review
</title>
      <pubDate>Fri, 05 Jan 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for iClick Interactive Asia Group Limited (NASDAQ:ICLK) in its $34.5 Million IPO</title>
      <pubDate>Wed, 03 Jan 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Expands Technology Practice with Addition of Scott Searle, CFA, Managing Director, Senior Research Analyst and transition of Brian Alger, CFA to Managing Director, Investment Banking</title>
      <pubDate>Wed, 03 Jan 2018 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>2017 ROTH Year in Review</title>
      <pubDate>Thu, 28 Dec 2017 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for Madrigal Pharmaceuticals, Inc. (MDGL) in its $143.7 Million Follow-On</title>
      <pubDate>Fri, 22 Dec 2017 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for Attunity Ltd. (ATTU) in its $23 Million Follow-On</title>
      <pubDate>Wed, 20 Dec 2017 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Manager for Myomo, Inc. (MYO) in its $10 Million Follow-On</title>
      <pubDate>Tue, 05 Dec 2017 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for Veritone, Inc. (VERI) in its $25.8 Million Follow-On</title>
      <pubDate>Thu, 30 Nov 2017 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for Century Casinos, Inc. (CNTY) in its $36.7 Million Follow-On</title>
      <pubDate>Wed, 29 Nov 2017 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title> Roth Capital Partners to Host 5th Annual ROTH Industrial Growth and Cleantech 1x1 Event in New York City</title>
      <pubDate>Tue, 28 Nov 2017 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Announces the Addition of Murray Huneke, Managing Director &amp; Co-Head of Consumer Investment Banking
</title>
      <pubDate>Thu, 09 Nov 2017 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Advises COBAN Technologies on its sale to Safe Fleet
</title>
      <pubDate>Wed, 08 Nov 2017 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host Technology Corporate Access Day in New York City, NY on November 15th, 2017</title>
      <pubDate>Mon, 06 Nov 2017 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Releases its 2017-2018 Millennial Survey</title>
      <pubDate>Mon, 06 Nov 2017 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for RumbleOn, Inc. (NASDAQ: RMBL) in its $16 Million Follow-On</title>
      <pubDate>Thu, 26 Oct 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host Private Capital Group: Family Office/Private Company Direct Investment Opportunities Event in Dallas, Texas, October 6th</title>
      <pubDate>Thu, 28 Sep 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Announces the Addition of Jotin Marango, M.D., Ph.D. and Yasmeen Rahimi, Ph.D. to its Healthcare Research Team</title>
      <pubDate>Wed, 20 Sep 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>29th Annual ROTH Conference | Ranked in the Top 100 Events in the United States in 2017 | #5 Business &amp; Financial Industry Event</title>
      <pubDate>Tue, 19 Sep 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Expands Resources Practice with Addition of Joseph (‚ÄúJ.‚Äù) Barry, Managing Director, Investment Banking and Jake Sekelsky, Research Analyst</title>
      <pubDate>Mon, 11 Sep 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host Solar &amp; Storage Symposium at Solar Power International (SPI 17)</title>
      <pubDate>Tue, 05 Sep 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Manager for Amtech Systems, Inc. (NASDAQ: ASYS) in its $11.5 Million Follow-On</title>
      <pubDate>Thu, 24 Aug 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for Lakeland Industries, Inc. (NASDAQ: LAKE) in its $10 Million Follow-On</title>
      <pubDate>Wed, 23 Aug 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host 3rd Annual Datacenter and Intelligent Infrastructure Corporate Access Day in San Francisco, Calif. on September 6, 2017</title>
      <pubDate>Tue, 22 Aug 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners&apos; John White Revisits one of the Strongest Plays in the Permian Basin
Featured: Roth Capital Partners, John White, Senior Research Analyst</title>
      <pubDate>Mon, 14 Aug 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Manager for FORM Holdings Corp. (NASDAQ: FH), in its $7.6 Million Follow-On</title>
      <pubDate>Mon, 07 Aug 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Placement Agent for Neovacs (Euronext Growth Paris: ALNEV) in its ‚Ç¨6.0 Million PIPE</title>
      <pubDate>Fri, 04 Aug 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for Apollo Endosurgery, Inc. (NASDAQ: APEN) in its $36 Million Follow-On</title>
      <pubDate>Wed, 26 Jul 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Announces the Addition of James Antonopoulos, Managing Director, Co-Head of Healthcare Investment Banking</title>
      <pubDate>Wed, 28 Jun 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for ShotSpotter, Inc. (NASDAQ: SSTI) in its $35.4M IPO</title>
      <pubDate>Tue, 13 Jun 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host Cleantech &amp; Industrial Growth 1x1 Event in London on June 21-22, 2017</title>
      <pubDate>Tue, 06 Jun 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for Asure Software, Inc. (NASDAQ: ASUR) in a $29.5 Million Follow-On</title>
      <pubDate>Fri, 02 Jun 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Expands Consumer Research Coverage with Addition of David B. Bain as a Senior Research Analyst in Gaming, Leisure and Lifestyle</title>
      <pubDate>Wed, 31 May 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for ASV Holdings, Inc. (NASDAQ: ASV) in its $26.6 Million IPO</title>
      <pubDate>Thu, 18 May 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Placement Agent for BioPharmX Corporation (NYSE: BPMX) in its $5.0 Million Registered Direct</title>
      <pubDate>Mon, 01 May 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Announces the Addition of Eric B. Cheng, Managing Director, Head of Healthcare Investment Banking</title>
      <pubDate>Thu, 27 Apr 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>How a Conference Transformed a Parking Lot for Three Back-to-Back Parties</title>
      <pubDate>Wed, 05 Apr 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Lead Placement Agent for Biocept, Inc. (NASDAQ: BIOC) in its $9.3 Million Registered Direct</title>
      <pubDate>Mon, 03 Apr 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>4th Annual ROTH China Solar Tour to be Held in Conjunction with SNEC Power Expo in Shanghai April 18-21, 2017</title>
      <pubDate>Thu, 30 Mar 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for MeetMe, Inc. (NASDAQ: MEET) in its $46 Million Follow-On</title>
      <pubDate>Tue, 28 Mar 2017 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners | 29th Annual Growth Stock Conference to be Held March 12-16, 2017</title>
      <pubDate>Wed, 08 Mar 2017 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>What Stumbling Blocks Are in Store This Year for Apparel Makers and Retailers?
Featured: Roth Capital Partners, Paul Zaffaroni, Managing Director, Investment Banking</title>
      <pubDate>Thu, 23 Feb 2017 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>The 10 best stock pickers that you should have listened to in 2016

Featured: Roth Capital Partners, Joseph Reagor, Research Analyst</title>
      <pubDate>Tue, 17 Jan 2017 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Placement Agent for The sonnen Group in its $85 Million Series D Round</title>
      <pubDate>Thu, 12 Jan 2017 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>The Kebab Shop wins minority investment for expansion</title>
      <pubDate>Tue, 10 Jan 2017 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH Advises The Kebab Shop on its Investment from AP Franchised Concepts</title>
      <pubDate>Tue, 10 Jan 2017 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for Polar Power, Inc. (NASDAQ: POLA) in its $19.3 Million IPO</title>
      <pubDate>Fri, 06 Jan 2017 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners appoints Michael Margolis, R.Ph. as Head of Healthcare Investment Banking</title>
      <pubDate>Fri, 06 Jan 2017 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for SenesTech, Inc. (NASDAQ: SNES) in its $15 Million IPO</title>
      <pubDate>Thu, 05 Jan 2017 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager and Sole Placement Agent For RedHill Biopharma Ltd. (RDHL) in its concurrent $24.4 Million Follow-On and $15 Million Registered Direct</title>
      <pubDate>Thu, 05 Jan 2017 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Lead U.S. Placement Agent for Pharming Group N.V. (EURONEXT: PHARM) in its ‚Ç¨104 Million Financing</title>
      <pubDate>Thu, 05 Jan 2017 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for BioPharmX Corporation (NYSE:BPMX) in its $13 Million Follow-On</title>
      <pubDate>Wed, 04 Jan 2017 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>2016 ROTH Year in Review</title>
      <pubDate>Fri, 30 Dec 2016 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for LightPath Technologies, Inc. (NASDAQ:LPTH) in a $9.7 Million Follow-On and renders a Fairness Opinion in connection with the acquisition of ISP Optics</title>
      <pubDate>Tue, 27 Dec 2016 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Honored by Global M&amp;A Network and M&amp;A Advisor</title>
      <pubDate>Mon, 19 Dec 2016 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Manager for Cherokee Inc. (CHKE) in its $40 Million Follow-On</title>
      <pubDate>Mon, 05 Dec 2016 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host New Industrials Corporate Access Day in New York City on December 13, 2016</title>
      <pubDate>Tue, 29 Nov 2016 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host Innovations in Oncology Corporate Access Day in New York on November 17, 2016</title>
      <pubDate>Fri, 04 Nov 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host Technology Corporate Access Day in New York City, NY on November 16, 2016</title>
      <pubDate>Tue, 01 Nov 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Releases its 2016-2017 Millennial Mom Survey</title>
      <pubDate>Thu, 13 Oct 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Zymergen Raises $130 Million for Robot-Powered Microbe Factory

Featured: Mark Breidenbach, Ph.D., Research Analyst, Roth Capital Partners</title>
      <pubDate>Tue, 11 Oct 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Financial Advisor on the Merger between Lucas Energy, Inc. and Segundo Resources, LLC</title>
      <pubDate>Wed, 05 Oct 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Mergers, Acquisitions and Bankruptcies: What‚Äôs in the Cards for the apparel and Retail Sectors

Featured: Paul Zaffaroni, Managing Director, Investment Banking, Roth Capital Partners</title>
      <pubDate>Thu, 29 Sep 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH Conference | Ranked in the Top 100 Events in the United States / #7 Business &amp; Financial Industry Event</title>
      <pubDate>Tue, 27 Sep 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Placement Agent for Roka Bioscience, Inc. (ROKA) in its $22.5 Million PIPE</title>
      <pubDate>Mon, 26 Sep 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for Capricor Therapeutics, Inc. (NASDAQ: CAPR) in its approximately $10 Million Follow-On Offering</title>
      <pubDate>Fri, 23 Sep 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Lead Manager for Callidus Software Inc. (NASDAQ: CALD) in its $93 Million Follow-On</title>
      <pubDate>Thu, 22 Sep 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host Solar &amp; Storage Symposium at Solar Power International Leading Solar Power, Storage, and Clean Technology Companies to Conduct Investor Meetings</title>
      <pubDate>Wed, 31 Aug 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host Datacenter Technology Corporate Access Day in San Francisco, Calif. on September 7, 2016</title>
      <pubDate>Thu, 25 Aug 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Expands Technology with Addition of Suji Desilva, CFA as a Senior Research Analyst in Technolog</title>
      <pubDate>Wed, 03 Aug 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>What Are the Roadblocks This Year for Apparel Makers and Retailers? Paul Zaffaroni, Managing Director, Roth Capital Partners</title>
      <pubDate>Thu, 28 Jul 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>The RLJ Companies and Roth Capital Partners Launch RLJ Capital Markets, a Full Service Minority Owner Investment Bank and Brokerage Firm</title>
      <pubDate>Mon, 11 Jul 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) in its $10 Million Follow-On Offering</title>
      <pubDate>Wed, 06 Jul 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Sole Placement Agent for Delcath Systems, Inc (NASDAQ: DCTH) in its $35 Million Convertible Senior Notes Offering.</title>
      <pubDate>Thu, 30 Jun 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for Uni-Pixel, Inc. (UNXL) in its $9.2 Million Follow-On</title>
      <pubDate>Tue, 14 Jun 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host 3rd Annual Healthcare Day In London on June 22nd, 2016</title>
      <pubDate>Mon, 13 Jun 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for BG Staffing, Inc. (BGSF) in its $16.7 Million Follow-On</title>
      <pubDate>Thu, 09 Jun 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for NV5 Global, Inc. (NVEE) in its $51.3 Million Follow-On</title>
      <pubDate>Wed, 08 Jun 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host Cleantech &amp; Industrial Growth Day in London on June 21, 2016</title>
      <pubDate>Mon, 06 Jun 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Advises Amsterdam-Based Joolz on Its Investment from Gimv</title>
      <pubDate>Tue, 31 May 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH China Solar Tour to be Held in Conjunction with SNEC Power Expo in Shanghai May 23-26, 2016</title>
      <pubDate>Mon, 16 May 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Manager for Global Water Resources, Inc. (GWRS) in its $8.4 Million IPO</title>
      <pubDate>Wed, 11 May 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for Revolution Lighting Technologies, Inc. (RVLT) in its $16.8 Million Follow-On</title>
      <pubDate>Tue, 10 May 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host Precious Metal Corporate Access Day in New York on May 18, 2016</title>
      <pubDate>Mon, 09 May 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Let Volatility Power Your Micro-Cap Biotechs

Featured: Joseph Pantginis, Ph.D., Senior Research Analyst &amp; Head of Biotechnology Research, Roth Capital Partners</title>
      <pubDate>Wed, 27 Apr 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Targets in the restaurant and healthy living subsectors are expected to continue to lead the charge of M&amp;A within the consumer/retail sector in H1 2016, as consumer tastes change.Featured: Paul Zaffaroni, Managing Director, Investment Banking, Roth Capital Partners</title>
      <pubDate>Fri, 08 Apr 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Seau fund gives $250K for adaptive surfing</title>
      <pubDate>Thu, 07 Apr 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Seau Foundation gives $250,000 to CAF</title>
      <pubDate>Thu, 07 Apr 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Southern California&apos;s Top 100 Events 2016
28th Annual ROTH Conference | Ranked #11 Trade Show &amp; Convention</title>
      <pubDate>Thu, 31 Mar 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>28th Annual ROTH Conference | Blind golfer&apos;s story resonates with many, including Aaron Rodgers</title>
      <pubDate>Thu, 17 Mar 2016 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners 28th Annual Growth Stock Conference to Be Held March 13-16, 2016</title>
      <pubDate>Wed, 09 Mar 2016 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Are Saudis Or U.S. Frackers The Swing Producer Of Oil?

Featured: John White, Senior Research Analyst, Roth Capital Partners</title>
      <pubDate>Mon, 22 Feb 2016 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Placement Agent for Galectin Therapeutics Inc. (GALT) in its $9.8 Million Registered Direct</title>
      <pubDate>Fri, 08 Jan 2016 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for IRadimed Corporation (IRMD) in a $29.1 Million Secondary Offering</title>
      <pubDate>Wed, 06 Jan 2016 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>CURBED ENTHUSIASM

Featured: John Chambers, Vice-Chairman and Vice-Chairman and Head of Healthcare Investment Banking, Roth Capital Partners</title>
      <pubDate>Mon, 04 Jan 2016 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole U.S. Placement Agent for Bionomics Limited in its $12 Million PIPE</title>
      <pubDate>Tue, 29 Dec 2015 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Why oil has just &apos;a glimmer of hope in 2016&apos;: Analyst

Featured: John White, Senior Research Analyst, Roth Capital Partners</title>
      <pubDate>Mon, 28 Dec 2015 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole U.S. Placement Agent for Viralytics Limited in its A$28.3 Million PIPE</title>
      <pubDate>Tue, 22 Dec 2015 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Paying It Forward: Byron Roth, MBA &apos;87 Chairman &amp; CEO, Roth Capital Partners</title>
      <pubDate>Tue, 15 Dec 2015 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host Immuno-Oncology Corporate Access Day in New York on December 16, 2015</title>
      <pubDate>Wed, 09 Dec 2015 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>We need meaningful cuts from OPEC

Featured: John White, Senior Research Analyst, Roth Capital Partners</title>
      <pubDate>Tue, 08 Dec 2015 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host New Industrials Corporate Access Day
Over 20 Growth Companies to Hold Investor Meetings</title>
      <pubDate>Mon, 07 Dec 2015 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for Energous Corporation (NASDAQ: WATT) in its $20.7 Million Follow-On</title>
      <pubDate>Fri, 04 Dec 2015 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Honored by Global M&amp;A Network</title>
      <pubDate>Mon, 09 Nov 2015 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Activist Pressure Could Lead Cabela&apos;s to Part Ways With Credit Card Business

Featured: Paul Zaffaroni, Managing Director, Roth Capital Partners</title>
      <pubDate>Wed, 04 Nov 2015 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Releases its 2015-2016 Millennial Mom Survey</title>
      <pubDate>Fri, 30 Oct 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to sponsor the 14th Annual Bio Investor Forum October 20-21, 2015 in San Francisco, CA.</title>
      <pubDate>Fri, 09 Oct 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for Pioneer Power Solutions, Inc. (Nasdaq: PPSI) in its $5.2 Million Follow-On</title>
      <pubDate>Wed, 07 Oct 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Mergers, Acquisitions and Reorganizations: Finance Leaders Take a Look at the Months Ahead

Featured: Paul Zaffaroni, Managing Director, Roth Capital Partners</title>
      <pubDate>Thu, 01 Oct 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host Solar Symposium on September 15, 2015 at Solar Power International (SPI 15)</title>
      <pubDate>Wed, 02 Sep 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for GigOptix, Inc. (GIG) in its $15.7 Million Follow-On</title>
      <pubDate>Tue, 01 Sep 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH Conference | Ranked in the Top 100 Events for United States &amp; Canada / #6 for Business &amp; Financial Industry Events</title>
      <pubDate>Wed, 26 Aug 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host DataCenter Technology Corporate Access Day in San Francisco, Calif. on September 9, 2015</title>
      <pubDate>Tue, 25 Aug 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners invests $13.5 Million into Revel Systems, Inc. through ROTH Revel I, LLC</title>
      <pubDate>Mon, 24 Aug 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for Pixelworks, Inc. (PXLW) in its $17.8 Million Follow-On</title>
      <pubDate>Wed, 12 Aug 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for General Employment Enterprises, Inc. (JOB) in its $8.7 Million Follow-On</title>
      <pubDate>Tue, 04 Aug 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for Redhill Biopharma Ltd. (RDHL) in its $44.5 Million Follow-On</title>
      <pubDate>Wed, 29 Jul 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Vista Outdoor to Acquire CamelBak for $413 Million

Featured: Paul Zaffaroni, Managing Director, Roth Capital Partners</title>
      <pubDate>Tue, 28 Jul 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for Tonix Pharmaceuticals Holding Corp. (TNXP) in its $20.1 Million Follow-On</title>
      <pubDate>Mon, 27 Jul 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for Eco-Stim Energy Solutions, Inc. (ESES) in its $29.3 Million Follow-On</title>
      <pubDate>Thu, 23 Jul 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners LLC was ranked #1 in PrivateRaise‚Äôs Q2 PIPE league tables</title>
      <pubDate>Thu, 23 Jul 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Expands Healthcare Banking Practice with Addition of Adam Stormoen as a Director, Investment Banking</title>
      <pubDate>Mon, 20 Jul 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>TIERS, SOME FEARS

Featured: John Chambers, Vice-Chairman and Vice-Chairman and Head of Healthcare Investment Banking, Roth Capital Partners</title>
      <pubDate>Mon, 13 Jul 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Manager for bluebird bio, Inc. (BLUE) in its $500 Million Follow-On</title>
      <pubDate>Mon, 06 Jul 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host Cleantech Day in London on June 25, 2015</title>
      <pubDate>Wed, 17 Jun 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Capitalize on Comeback Stories in Micro-Cap Biotech: Joe Pantginis of Roth Capital Partners</title>
      <pubDate>Wed, 17 Jun 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners to Host Healthcare Day in London on June 24, 2015</title>
      <pubDate>Tue, 16 Jun 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Challenge Athletes Foundation Raises More Than $2 Million at Ninth Annual Gala in New York City</title>
      <pubDate>Fri, 12 Jun 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for NV5 Holdings, Inc. (NASDAQ: NVEE) in its $32 Million Follow-On</title>
      <pubDate>Thu, 28 May 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH Advises Eureka! Restaurant Group on its Investment from KarpReilly

</title>
      <pubDate>Mon, 11 May 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Eureka! receives investment from KarpReilly</title>
      <pubDate>Mon, 11 May 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Former Wedbush Technology Fund PM Joins Roth Capital Partners

Featured: Senior Research Analyst, Brian Alger, CFA</title>
      <pubDate>Fri, 08 May 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH Advises Diono on its Investment from Winona Capital</title>
      <pubDate>Fri, 08 May 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Expands Technology with Addition of Brian Alger, CFA as a Senior Research Analyst in Technology

</title>
      <pubDate>Thu, 07 May 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Challenged Athletes Foundation (CAF) to Celebrate Unbreakable Athletic Spirit at Ninth Annual Gala in New York City

Honoree: Byron Roth, Chairman &amp; CEO, Roth Capital Partners</title>
      <pubDate>Fri, 01 May 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Expands Healthcare Practice with Addition of Michael Higgins as a Senior Research Analyst ‚Äì Specialty Pharmaceuticals/Biotechnology</title>
      <pubDate>Mon, 27 Apr 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>ROTH China Solar Tour to be Held in Conjunction with SNEC Power Expo in Shanghai April 28-30, 2015

ROTH Investor Tour to Meet with 20 Solar Power and Clean Technology Companies on Booth Tours and Facility Visits</title>
      <pubDate>Thu, 16 Apr 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for Conatus Pharmaceuticals Inc. (CNAT) in its $23.1 Million Follow-On</title>
      <pubDate>Fri, 10 Apr 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Expands Banking Practice with the Addition of David T. Farina, CFA as a Managing Director, Investment Banking</title>
      <pubDate>Thu, 26 Mar 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Southern California&apos;s Top 100 Events 2015. The list of the meetings, parties, and industry gatherings that make the most impact in Southern California year after year. 27th Annual ROTH Conference ranks #11 for Trade Shows &amp; Conventions.</title>
      <pubDate>Tue, 24 Mar 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>27th Annual ROTH Conference: Equities.com Interviews</title>
      <pubDate>Wed, 18 Mar 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Co-Lead Manager for Callidus Software Inc. (NASDAQ: CALD) in its $69 Million Follow-on</title>
      <pubDate>Tue, 17 Mar 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Inside ROTH: Equities.com Recaps One of the Best Small-Cap Investment Conferences on Wall Street</title>
      <pubDate>Mon, 16 Mar 2015 00:00:00 -0400</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for RedHill Biopharma Ltd. (Nasdaq:RDHL) in its $14.4 Million Follow-On

</title>
      <pubDate>Thu, 05 Mar 2015 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as sole book-running manager for MoSys, Inc. (NASDAQ: MOSY) in its $23 Million Follow-on</title>
      <pubDate>Wed, 04 Mar 2015 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Sole Book-Running Manager for ImmunoCellular Therapeutics, Ltd. (IMUC) in its $16 Million Follow-On</title>
      <pubDate>Tue, 03 Mar 2015 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>27th Annual ROTH Conference on March 8-11, 2015 - To Host More Than 530 Public and Private Companies</title>
      <pubDate>Wed, 25 Feb 2015 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager for Tonix Pharmaceuticals Holding Corp. (TNXP) in its $31.1 Million Follow-On</title>
      <pubDate>Wed, 25 Feb 2015 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>ROTH Cleantech Banking Team has Record 2014
22 Equity, Debt, and M&amp;A Transactions Completed</title>
      <pubDate>Thu, 19 Feb 2015 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Joint Book-Running Manager in the $49.5 Million IPO and Financial Advisor in the $15 Million Private Placement for Zosano Pharma Corporation (Nasdaq: ZSAN)</title>
      <pubDate>Wed, 11 Feb 2015 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Execs upbeat heading to J.P. Morgan Healthcare Conference</title>
      <pubDate>Mon, 12 Jan 2015 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Roth Capital Partners Acts as Advisor to Pioneer Power Solutions, Inc. (PPSI) in its Acquisition of Titan Energy Worldwide, Inc.</title>
      <pubDate>Wed, 07 Jan 2015 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Pro predicts $75 oil for 2015</title>
      <pubDate>Mon, 05 Jan 2015 00:00:00 -0500</pubDate>
    </item>
  </channel></rss>